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Zusammenfassung 
Mein Ziel war es, genetische Faktoren in C. elegans zu identifizieren, die eine Rolle bei 
induzierter Transdifferenzierung durch Missexpression des Transkriptionsfaktors (TF) HLH-1, 
welcher das Wurmhomolog des myogenen bHLH TF MyoD ist, spielen. Ich entwickelte hierzu 
einen semiautomatischen Hochdurchsatz-Vorwärtsgenetik-Screen, indem ich EMS Mutagenese 
mit dem Biosorter-System (Union Biometrica) kombinierte. Missexprimiert kann HLH-1 
Muskelentwicklung in frühen embryonalen Zellen induzieren, aber terminal differenzierte Zellen 
in älteren Tieren sind gegenüber HLH-1-induziertem direktem Reprogrammieren resistent. Um 
Mechanismen zu identifizieren die HLH-1-induziertem direktem Reprogrammieren in terminal 
differenzierten Zellen entgegenwirken, nutzte ich für meinen Screen eine transgene Linie, die 
ektopische Expression von hlh-1 ermöglicht und des Weiteren einen transkriptionellen Reporter 
für Muskelzellen besitzt (myo-3p::gfp::NLS). Mit diesem Ansatz ist es mir gelungen, die Mutante 
bar18 zu isolieren, die eine Anhäufung an Muskelzellkernen um den posterioren Teil des Pharynx 
zeigt. Ich identifizierte den mutierten Lokus, indem ich das gesamte Genom sequenzierte und 
charakterisierte den mutanten Phänotyp im Detail.  
Zusätzlich war ich bei der Charakterisierung  von Faktoren, die das Umprogrammieren zu 
neuronalen Zellen in C. elegans verhindern, beteiligt. Dabei stand der sogenannte  FACT-
Komplex im Focus, welcher mittels eines genom-weiten RNAi-Screen in unserer Arbeitsgruppe  
identifiziert wurde1. Dieser Rückwärtsgenetik-Screen zielte, im Gegensatz zum Vorwärtsgenetik-
Screen den ich durchführte, darauf ab, Faktoren zu identifizieren, die bei der induzierten 
Transdifferenzierung durch Missexpression von dem TF CHE-1 eine Rolle spielen. CHE-1 ist ein 
Zinkfinger-TF und essentiell für die terminale Differenzierung der glutamatergen ASE-Neuronen. 
Interessanterweise ist eine der FACT-Komplex-Untereinheiten, spt-16, das parentale Gen zu dem 
bislang nicht charakterisierten Pseudogen F55A3.7. Eine putative Null-Mutante von F55A3.7, in 
Kombination mit ubiquitärer Überexpression von CHE-1, zeigte einen Keimzellen-zu-Neuronen 
Transdifferenzierungsphänotyp ähnlich dem Phänotypen, der nach dem Knock-down der FACT-
Komponente hmg-3 beobachtet wird. Unseres Wissens nach ist dies das erste Beispiel einen 
Pseudogens, dessen Knock-down dazu führt, dass ein bestimmtes Gewebe durch einen terminalen 
Selektor-TF reprogrammiert werden kann, dessen Expression unter normalen Konditionen dies 
nicht zur Folge hätte. Aufgrund dieser Einzigartigkeit, habe ich das Pseudogen F55A3.7 
charakterisiert und außerdem versucht, einen Mechanismus zu finden, wie F55A3.7 die 
Keimbahnidentität schützt. 
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Abstract 
My aim was to identify and characterize genetic factors in C. elegans that play a role in 
induced transdifferentiation by mis-expressing the transcription factor (TF) HLH-1, which is 
the worm homolog of the myogenic bHLH TF MyoD. For this, I developed a semi-automated 
high-throughput forward genetic screen combining EMS mutagenesis with the Biosorter 
system (Union Biometrica). When mis-expressed, HLH-1 induces the muscle fate in early 
embryonic cells, but terminally differentiated cells in older animals are resistant to HLH-1-
induced direct reprogramming. In order to identify mechanisms that antagonize HLH-1-
induced reprogramming in ectopic tissues, I used a transgenic line allowing ectopic 
expression of the hlh-1 gene in combination with a reporter for muscle fate (myo-
3p::gfp::NLS) for my screen. Using this approach, I isolated the mutant bar18, showing an 
accumulation of muscle cell nuclei around the posterior pharyngeal bulb of the worm. I 
identified the mutated locus using whole genome sequencing (WGS) and characterized the 
identified gene and the mutant phenotype further. 
Additionally, I was also involved in helping to characterize the FACT complex, which was 
identified through a whole-genome RNAi screen conducted by my colleague Ena Kolundžić1. 
This reverse genetic screen, in contrast to the forward genetic screen that I performed, aimed 
at identifying factors that play a role in induced transdifferentiation by mis-expressing the TF 
CHE-1, a Zn-finger TF essential for terminal differentiation of glutamatergic ASE neurons. 
Interestingly, one of the FACT complex members, spt-16, is the parental gene of a previously 
uncharacterized pseudogene named F55A3.7. A putative null mutant of F55A3.7, combined 
with broad overexpression of CHE-1, showed a germ cells to neurons transdifferentiation 
phenotype similar to the phenotype observed after depleting the FACT member hmg-3. To our 
knowledge, this is the first example of a pseudogene whose depletion leads to the 
permissiveness of a certain tissue to be reprogrammed when challenged by a terminal selector 
TF. Due to this uniqueness, I characterized the pseudogene F55A3.7 and tried to find a 
potential mechanism for how F55A3.7 safeguards germline identity. 
Keywords:  
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Preface 
The basis for this research, for my thesis, originally stemmed from my passion for genetics 
and developmental biology. I was always curious about the act of undifferentiated cells 
undergoing specialization, forming tissues, organotypic structures and whole organisms. The 
translation of intracellular alterations into observable tissue patterns with their associated 
functions is extremely exciting and lets us embrace the beauty of nature on a molecular level. 
My ride was not easy though and sometimes I had the feeling there were more downs than 
ups. For three years I was riding a dead horse - a crazy project that I had to drop because it 
was leading nowhere. On the other hand, isn’t a smooth ride boring? And whose PhD is 
running smoothly anyways? The ones I’ve heard of are fairytales I believe.  
What really matters is the knowledge I gathered, the skills I learned, the amazing experiences 
I had and the wonderful people I met on my way. I would have never wanted to miss out of all 
these opportunities and the most inspiring and interesting time of my life so far. 
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1 Introduction 
 
1.1 Maintenance of cell identities and cell function 
The idea that terminally differentiated cells are irreversible committed to a certain cell identity 
has been challenged several times throughout the history of modern biology. Pioneering work 
that showed that terminally differentiated cells still possess a certain plasticity has been done 
by Gurdon in the fifties2 and Wilmut in the nineties3. Both could show that the transplantation 
of a somatic, terminally differentiated nucleus into an unfertilized denucleated oocyte could 
eventually lead to reprogramming of the somatic nucleus and ultimately resulted in the 
cloning of frogs2 and the sheep Dolly3. Direct reprogramming or transdifferentiation by 
ectopic expression of cell-fate inducing TFs was first demonstrated in the eighties by the 
Weintraub lab4. Davis and colleagues could show that transfecting fibroblasts with a cDNA 
encoding the TF MyoD is sufficient to convert them into contracting myoblasts. Another 
milestone in the field was the discovery by Takahashi and Yamanaka, that four specific 
transcription factors (TFs), OCT4, SOX2, KLF4 and c-MYC, also collectively referred to as 
OSKM, could convert mouse fibroblasts to a pluripotent cell type called induced pluripotent 
stem cells (iPSCs)5. iPSCs have similar morphology, gene expression profiles and growth 
properties as embryonic stem cells (ESCs). Importantly, those cells form teratomas when 
injected into mice, which are tumors that consist of cells from all three germ layers, thus 
ultimately confirming their pluripotency.  
The concept that terminally differentiated cells are stably, rather than terminally, committed6, 
has inspired many labs to screen for reprogramming barriers in different species. 
Reprogramming barriers usually ensure that specific cell identities are being maintained in an 
organism. C. elegans is a powerful model organism to identify and study such reprogramming 
barriers in vivo. The chromatin regulator FACT (facilitates chromatin transcription) for 
instance, was identified in C. elegans as a reprogramming barrier for the transdifferentiation 
of germ and intestinal cells to neurons1. Strikingly, FACT’s role as a barrier to cell fate 
conversion is conserved in H. sapiens, confirming the potential of using C. elegans as a 
system to identify evolutionary conserved reprogramming barriers. 
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Besides reprogramming barriers, there are many other maintaining mechanisms and factors 
ensuring that a certain cell type is properly fulfilling its specific functions. LINC (Linker of 
Nucleoskeleton and Cytoskeleton) complexes, for instance, fulfill many different roles that 
are crucial in this regard, from ensuring proper nuclear movement and anchoring, to moving 
meiotic chromosomes and telomeres or sensing mechanic stimuli7–10. They are widely 
conserved too, including nematodes, plants and mammals and a lot of our current 
understanding about LINC complexes is due to studies that have been done in the worm.   
C. elegans with its invariant cell lineages is an excellent model to study maintenance in 
general, be it maintenance of cell identities, maintenance of cell number or cell position, 
amongst many others. The specific advantages of C. elegans as a model organism are being 
discussed in the next section.   
 
1.2 C. elegans as a model system 
Caenorhabditis elegans (C. elegans) is a non-parasitic nematode of about 1 mm in length and 
lives on rotten vegetable or fruit matter that contains a bacterial food source11. It can be found 
all over the world and was first isolated as a model organism in Bristol in 1963 by Sydney 
Brenner12. Under laboratory conditions, it is usually grown on agar plates seeded with 
Escherichia coli (E. coli) as a food source or in liquid culture containing E. coli. 
C. elegans has a cylindrical body shape and consists, like other nematodes, of several 
specialized tissues (Figure 1). Cuticle, hypodermis, excretory system, neurons and body wall 
muscles form the outer tube of the worm, while pharynx, intestine and gonad belong to the 
inner tube. Both tubes are separated by the so-called pseudocoelomic space. 
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Figure 1. C. elegans. Adult hermaphrodite (above) and male (below). Lateral views, bright field illumination. 
Scale bar = 20µm. Figure adapted from Sulston and Horvitz, 197713.  
 
They are translucent, which easily allows microscopic imaging of all tissues in vivo, using e.g. 
differential interference contrast (DIC) microscopy, but also fluorescent microscopy, which 
takes advantage of the possibility to express reporter genes in a cell- or tissue-specific manner 
(Figure 2). 
14 
 
 
Figure 2. Tissue specific in vivo labelling in C. elegans. C. elegans is a translucent organism. Using tissue 
specific promoters to drive the expression of reporter genes allows labeling of subsets of cells in the worm. 
Picture: Tursun et al., Hobert et al.  
Besides its translucency, C. elegans has several other features that make it an excellent model 
organism. It has a rapid life cycle (~3 days from egg to an egg-laying adult at 25 °C) and 
exists primarily as a self-fertilizing hermaphrodite, although males occur spontaneously with 
a frequency of < 0,2 % within a population. Furthermore, it is a eutelic organism (Section 
1.1.1), meaning that it is composed of a fixed number of somatic cells: hermaphrodites consist 
of 959 cells, whereas males have 1.031 cells. Self-fertilized hermaphrodites lay up to 300 
eggs, while hermaphrodites inseminated by males lay up to 1000.  
The life cycle of C. elegans consists of embryogenesis (~13h), the larval stages L1-L4 (~28h) 
and adulthood (Figure 3). Embryogenesis can be divided into an in utero (mostly 
proliferation) and an ex utero development, which starts after egg laying coinciding roughly 
with the beginning of gastrulation14,15. The so-called ‘lima bean’ stage marks the beginning of 
morphogenesis and elongation. After a quickening phase, marked by the beginning of muscle 
movements, animals hatch and pass through the larval stages L1-L4. The reproductive system 
is already established during larval development and is fully developed as the worms reach 
adulthood. At 22-25 °C, hermaphrodites start laying their first eggs approximately 45-50 h 
after hatching. Unfavorable conditions such as starvation, high temperatures or crowding can 
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lead to alternative larval forms like L1 arrest or Dauer. During these stages, further 
development is arrested and locomotion is reduced. Once more advantageous conditions 
return, development continues: L1 arrested animals molt and develop to L2 larvae, while 
Dauer worms develop into L4 larvae.  
 
Figure 3. Life cycle of C. elegans at 22 °C. The life cycle of C. elegans consists of embryogenesis (~13h), the 
larval stages L1-L4 (~28h) and adulthood. Unfavorable conditions like starvation, high temperatures or crowding 
can lead to alternative larval forms like L1 arrest or Dauer. Picture taken from www.wormatlas.org 
C. elegans was the first multi-cellular organism to have its genome sequenced (C. elegans 
Sequencing Consortium 1998). It has five autosomes and one sex chromosome: 
hermaphrodites carry a matched pair of sex chromosomes (XX), while males carry only one 
(X0)16. Although the number of protein coding genes between humans and C. elegans is 
comparable (both have around ~20000), the genome of C. elegans is much smaller as 
compared to humans (~100Mb organized in 6 chromosomes vs. ~3200Mb organized in 23 
chromosomes). Remarkably, over two-thirds of human protein coding genes have homologs 
in C. elegans17. Important molecular pathways such as Wnt, Notch and Insulin signaling are 
conserved between C. elegans and humans18.  
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Taken together, C. elegans offers several features that make it an excellent model organism: 
its small size and translucency, a rapid life cycle and being primarily hermaphroditic, a well 
annotated genome allowing genetic screens and manipulations as well as having homologs to 
many human protein coding genes, including many important molecular pathways. 
Furthermore, C. elegans offers eutely and its complete lineage has been mapped (Section 
1.1.1). 
 
1.2.1 Eutely and cell lineage in C. elegans 
Eutely, or cell constancy, refers to organisms that have a constant number of somatic cells 
when they reach adulthood19,20. After fertilization and initial proliferation, each embryonic 
cell possesses a limit for total cell divisions. After each cell has reached its limit and the total 
number of cells is established, somatic development stops and the organism can only become 
bigger due to cell enlargement (hypertrophy) rather than through cell division. 
Eutelic animals are usually microscopically small and consist of less than 100.000 cells. 
Examples include rotifers, tardigrades, gastrotrichs, dicyemids and nematodes. Amongst 
nematodes, maritime nematodes are an exception, since they don’t display eutely and thus 
have an undefined number of total cells21. Eutely allows the analyzation of the developmental 
history of each cell in the whole organism, tracing its individual lineage back to fertilization. 
It is also a nicely exploitable trait for experiments that aim to identify genes involved in 
lineage decisions and (terminal) differentiation. This is especially true for forced 
transdifferentiation experiments, as the readout of such experiments is usually a tissue-
specific reporter gene.  
C. elegans is the best studied eutelic organism to date and its whole cell lineage is 
mapped13,22, meaning that every single cell division, as well as each apoptotic event, has been 
described (Figure 4A).  
17 
 
Figure 4. Cell lineages of C. 
elegans. 
A) Embryonic (black) and post-
embryonic (red) lineage of C. elegans 
hermaphrodites. Every single cell 
division and apoptotic event known is 
shown. Picture by Sulston and 
Horvitz, taken and adapted from 
www.wormatlas.org 
B) Simplified schematic overview of 
the lineage of C. elegans’ 
hermaphrodites, including lineage 
nomenclature and types of tissues 
that originate from different lineages. 
Picture by John Yochem and Robert 
K. Herman23. 
 
 
After the haploid oocyte is fertilized with a haploid sperm, originating either from the 
hermaphrodite itself or from a male, a single-cell diploid embryo is formed. Following the 
first cell division, the resulting 2-cell embryo consists of an AB and a P1 cell, which further 
proliferate and give rise to several other subordinated lineages. The vast majority of body 
muscles, the germline and the intestine arise from the P1-cell, while almost all body neurons 
and the majority of the epidermis arise from the AB cell (Figure 4B). The adult epidermis 
(also: hypodermis) is mostly syncytial, which means that most of its cells are multinucleated -
a result of several cell fusions during larval development. While most hypodermal cells 
consist of less than 10 nuclei in the adult hermaphrodite, the hyp7 cell consists of 13924. 
 
1.2.2 The C. elegans muscle system 
C. elegans consists of two different types of muscles, striated (somatic) and nonstriated 
(single sarcomere) muscles25. The somatic (multiple sarcomere) muscles have attachment 
points to both the hypodermis and the cuticle. They consist of 95 so-called body wall muscles 
organized in four quadrants (Figure 5), 81 of which are born during embryonic development, 
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Figure 5. Arrangement of body wall muscles in C. elegans. The hermaphrodite is dissected along the dorsal 
midline and flattened, so that the ventral part in the middle is facing the viewer. Each quadrant contains 24 body 
wall muscle cells, except for the ventral left quadrant, which contains only 23. The lineage of which the different 
cells originated from is indicated. Post-embryonically born cells are shown in solid green. (dm) Dorsal midline; 
(vm) ventral midline. Picture taken from www.wormatlas.org 
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while 14 are generated post-embryonically during the transition from the L1 to the L2 larval 
stage. In contrast, the majority of nonstriated muscles have focal attachment points at their 
ends. They consist of 20 pharyngeal muscles, two stomatointestinal muscles, eight vulval 
muscles, eight uterine muscles, one anal sphincter muscle, one anal depressor muscle and the 
contractile gonadal sheath. Males obviously lack vulval and uterine muscles (as well as 
gonadal sheath), but have 41 specialized mating muscles instead. In general, all muscle cells 
are mononucleated, with the exception of the pharyngeal cells pm1-pm5, which fuse after 
hatching, resulting in a six nuclei pm1 syncytium and the five binucleated syncytial cells 
pm2-pm5. 
Contractions and relaxations of the striated body wall muscle cells lead to the sinusoidal 
‘elegant’ movement of the worm. C. elegans’ somatic muscles send extensions to the dorsal 
and ventral nerve cord to connect to synapses, which is atypical, as for most animals muscles 
would receive axonal projections from motor neurons and not the other way around26. The 
first cloning and sequencing of a myosin gene happened in C. elegans in 1981 (unc-54)27 and 
provided major insights into our understanding of myosin structure. There are many other so 
called unc genes, whose depletion leads to a phenotype of impaired movement (uncoordinated 
or Unc) and many of those are genes needed for proper muscle activity. On the other hand, not 
every myosin-encoding gene is termed an unc gene. One prominent example is myo-3, which 
encodes MHC A, the minor isoform of MHC (myosin heavy chain)28.  
myo-3 is primarily expressed in body wall muscles, but also in the somatic sheath, in enteric 
muscles, vulval muscles of the hermaphrodite and the diagonal muscles of the male tail29. Due 
to the equal and strong expression in all four quadrants of body wall muscles, the promoter of 
myo-3 is widely used for reporters constructs (Figure 6). 
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Figure 6. A myo-3p::gfp::NLS construct equally stains all four body wall muscle quadrants. Body wall 
muscle nuclei of each quadrant are consecutively numbered. Vulva nuclei on the ventral side are smaller in size 
and easily distinguishable from body wall muscle nuclei. (NLS) nuclear localization signal, (VR) ventral right, 
(VL) ventral left, (DL) dorsal left, (DR) dorsal right. Anterior is to the left.  
 
1.2.3 The C. elegans gonad 
In hermaphrodites, the gonad consists of two mirror-image U-shaped tubes, while in males it 
consists of a single U-shaped lobe only. The gonad consists of a somatic part and the 
germline, where oocytes (hermaphrodites only) and sperm (both hermaphrodites and males) 
develop30. The developmental roots of the germline can be found in early embryogenesis, 
where P blastomeres carry germline potential until P4 is born - the germline founder cell 
(Figure 7A). P4 is the first cell that gives rise to germ cells only and does not contribute to the 
soma at all.  
Early germline specification is mediated by P granules, which are maternally provided 
ribonucleoprotein particles that are segregated to the P blastomeres. In the absence of P 
granules, germline development is severely impaired. Still, they are not sufficient for 
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specifying the germ cell fate. Besides P granules, the PIE-1 protein plays a crucial role in 
specifying the germline fate. PIE-1 is a maternally provided transcriptional repressor and 
keeps the early germline blastomeres in a transcriptionally silent state. MES-protein-mediated 
regulation of the chromatin state is believed to ensure the correct pattern of gene expression 
once the PIE-1 mediated transcriptional suppression ends31. 
Freshly hatched L1 larvae display four gonadal precursor cells: two primordial germ cells (Z2 
and Z3) and two somatic gonad precursors (Z1 and Z4). Until mid-L1, those four cells are 
quiescent. Following this state, the somatic gonad develops in tandem with the germline 
(Figure 7B). The somatic precursors Z1 and Z4 proliferate to 12 cells by the end of the L1 
stage: 10 proximal cells that will form the hermaphrodite somatic gonad primordium in late 
L2 stage and two distal tip cells (DTCs) that are crucial for the proliferation of the germ line. 
By the early L3 stage, the gonadal arms turn and extend rapidly, while the germ line 
proliferates in response to the DTC and the somatic sheath.  
At the late L3 stage, first germ cells start to enter meiosis and a meiotic zone develops, which 
is growing in size during L4 development. By the late L4 stage, the germline is subdivided 
into a distal mitotic zone, a transition zone, a meiotic zone and proximal zone where 
spermatogenesis is happening. GLP-1 signaling, in a response of the DTC, inhibits the entry 
into meiosis in the mitotic zone. The genetic regulation of meiotic entry is complex and 
includes post-transcriptional gene regulators such as GLD-1, GLD-2, FBF-1/2 and NOS-3.  
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Figure 7. Gonadogenesis in C. elegans (A) Fertilization and the embryonic germline. Embryonic development 
initiates after fusion of oocyte and sperm. P cells carry germline potential and divide unequally until P4, which is 
the first cell that does not contribute to the soma and divides equally into Z2 and Z3. Germline lineages are 
depicted in yellow. (B) Post-embryonic hermaphrodite gonad development. Germline color scheme: yellow = 
mitotic region, light green = transition zone (early prophase of meiosis I), dark green = pachytene, dark blue = 
spermatogenesis, pink = oogenesis. In the late-L3 and late-L4 stages, the mitosis/meiosis border is indicated. In 
adults the mitosis/meiosis border is not sharp and mitotic and meiotic nuclei are interspersed at the border 
(indicated by a yellow/green color gradient). Somatic gonad color scheme: red = DTC, blue = 
sheath/spermatheca precursor cells, light blue = sheath nuclei, grey = spermatheca, white = uterus. Germline 
nuclei and their surrounding cytoplasm are often referred to as ‘germ cells’, although they are open to a core of 
shared cytoplasm (rachis) during most of their development. Picture by Jane Albert Hubbard and David 
Greenstein and taken from www.wormbook.org. 
Spermatogenesis is finished at the adult stage, when sperm cells are stored in the spermatheca. 
In contrast to male gametes, that’s the time point when oogenesis starts in hermaphroditic 
gonads and it continues throughout adulthood. Oocytes exhibit a huge cytoplasmic volume, as 
compared to germ cells, so that they can support early embryogenesis. Many female germ 
cells do not mature to oocytes, but undergo apoptosis. This is happening mostly at the gonadal 
turns (the so called death zone) and apoptotic germ cells are engulfed by gonadal sheath cells. 
Female germ cells that do not undergo apoptosis and mature to oocytes get either self-
fertilized with sperm from the spermatheca or, alternatively, get fertilized by foreign sperm of 
a male. After fertilization, there is a short period of in utero development (2.5h at 20 °C), after 
which the developing embryos are laid as eggs.  
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1.3 Principles of genetic screens in C. elegans 
C. elegans is highly amenable to genetic screens due to its short generation time, its 
hermaphroditic lifestyle and ease of use for both mutagenesis and RNA interference (RNAi) 
knock-down experiments. There is a wealth of gene-alteration techniques available, as well as 
ready to use RNAi libraries, overall making C. elegans a powerful tool for genetic screens.  
 
1.3.1 Forward genetic screens 
In a forward genetic screen a geneticist isolates mutants that display a phenotype of interest 
and tries to identify the mutated gene retrospectively. Often such mutations cause loss of 
function alleles, such as deletions, frameshifts, or premature STOP codons. Some of the first 
screens were performed using bacteria, as early as the 40s during the last century. For 
instance, Luria and Delbrück isolated bacterial mutants that were resistant to the 
bacteriophage T1, since they had lost the respective receptor32. The first mutagenesis screen in 
C. elegans was done in 1967 by Sydney Brenner, who published his results in 197412. He 
isolated approximately 100 mutants that were viable and displayed visible phenotypes using 
chemical mutagenesis with Ethyl-Methane-Sulfonate (EMS). A schematic of an EMS 
mutagenesis can be found in Figure 8.   
Besides EMS, several other chemical mutagens have been applied to the worm in order to 
perform forward genetic screens, including trimethylpsoralen with ultraviolet light 
(TMP/UV)33, N-ethyl-N-nitrosourea (ENU)34, formaldehyde35, nitrosoguanidine (NTG)36, 
diethyl sulfate (DES)36, acetaldehyde36, diepoxyoctane (DEO)37 and diepoxybutane (DEB)38. 
EMS is not only the first mutagen ever applied to C. elegans, but still the most commonly 
used and potent one. It is an alkylating agent and most commonly adds an ethyl group to 
guanine to form O6-ethylguanine39. In subsequent replications, this modified guanine 
inappropriately pairs with thymine40, causing G/C to A/T transitions, which often leads to the 
generation of stop codons41. Such mutations are typically strong loss-of-function or null 
alleles. Besides point mutations, about 13% of EMS lesions are deletions or other 
chromosomal rearrangements42. 
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Figure 8. Schematic of a simple 
F2 mutagenesis screen. WT 
hermaphrodites are exposed to a 
mutagen and genes are randomly 
mutated in both somatic and germ 
cells (mutated germ cells are 
indicated in orange). For 
example, one sperm could be 
mutated for a specific gene, 
which depletion would result in 
ectopic GFP signals of a muscle-
specific reporter. Fertilization of 
an egg by this sperm would result 
in a heterozygous F1 individual. 
Since this worm would be a self-
fertilizing hermaphrodite, one-
quarter of its F2 progeny would 
be homozygous for the mutation 
and display ectopic GFP. Such a 
F2 animal can be singled to a 
fresh plate and its F3 progeny can 
be inspected for homozygosity. 
Anterior is to the left. Image 
modified from Jorgensen & 
Mango43 by Baris Tursun.  
 
 
For the sake of completeness, it should be mentioned that apart from chemical mutagens, 
genome wide forward genetic screens in C. elegans can be also done by using high-energy 
radiation (ultraviolet light44, ionizing radiation45 and 32P decay46) or transposons (Mos1 
transposase47–49).  
 
1.3.2 Reverse genetic screens 
In a reverse genetics screen a geneticist knocks out or knocks down genes of interest and 
analyses the resulting phenotypes. For small-scaled screens, knock-outs can be done using 
targeted mutagenesis, which aims to generate lesions in a specific gene of interest. Different 
methods of targeted mutagenesis exist and, as the name implies, just modify the targeted 
locus. In order to do so, the DNA double helix has to be cut, which can be achieved in two 
different ways: either by a transposon excision or by an enzyme, both of which will be 
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discussed in a later section. Off-target effects might still occur though, but can be dealt with 
by outcrossing mutant strains (such as it is usually done upon random mutagenesis in a 
forward genetic screen discussed in the previous section). Large scale screens usually rely on 
the use of RNAi. 
 
1.3.2.1 Targeted mutagenesis  
Historically, point mutations, small deletions, and insertions (e.g., of GFP) were introduced 
into a C. elegans gene of interest using Mos1 excision-induced Transgene-Instructed gene 
Conversion (MosTIC)50. A similar strategy, Mos1-mediated Deletion (MosDEL), can be used 
to introduce large deletions (up to 25 kb) at specific sites51,52. Mos1-mediated Single Copy 
Insertion (MosSCI), a related method which also uses homologous repair after transposon 
excision, is not a mutagenic technique per se, but should be mentioned here for the sake of 
completeness. It can be used to introduce single copies of a transgene into a specific genomic 
site52,53. 
Enzymatic methods of targeted mutagenesis include Zinc finger nucleases (ZFNs)54, 
transcription activator-like effector nucleases (TALENs)55, and the CRISPR/Cas system 
(reviewed by Wiedenheft et al.56), summarized in Figure 9. ZFNs and TALENs are relatively 
complicated to design and expensive, whereas the CRISPR/Cas system is not.  
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Figure 9. Enzymes to generate DSBs at specific loci: ZFNs, TALENs, CRISPR/Cas. (A) Two ZFNs are 
targeted to a locus of interest such that their FokI nuclease domains dimerize to generate a DSB. (B) Like ZFNs, 
TALENs are targeted to a specific locus, where they generate a DSB upon dimerization of their FokI domains. 
(C) In the CRISPR/Cas9 system, Cas9 is guided by a guide RNA that recognizes a 20-bp region in the genome. 
The Cas9/gRNA complex binds and introduces a DSB 3 bp upstream of the PAM motif (NGG). (D) Cas9 
nickases (Cas9n) are mutant variants that possess a nickase activity and thus cannot cause a DSB on their own. 
Two nicks (one sense and one anti-sense) are needed to cause a DSB. (E) A similar strategy to avoid off-target 
effects uses catalytically inactive Cas9 fused with a FokI nuclease domain (fCas9). Only when two FokI 
nuclease domains dimerize, a DSB is caused. Image by Ott de Bruin et al.57 
 
The discovery of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
and CRISPR-associated (Cas) system pushed genome editing to the next level. CRISPR/Cas 
is an adaptive immune system against viruses and plasmids (reviewed by Wiedenheft et al.56). 
The bacterial cell uses an RNA guide to target a Cas protein to a piece of foreign DNA in 
order to cleave it (Figure 9C). Different guide sequences to target foreign DNA can be stored 
in the bacterial genome (memory of the adaptive immune system). For cleavage in vitro, the 
minimal components required for the Type II CRISPR system are a synthetic single guide 
RNA and the Cas9 nuclease from Streptococcus pyogenes58. Target specificity is provided by 
a 20-bp sequence within the guide RNA. The only constrain is a Protospacer-Adjacent Motif 
(PAM) after the 3’ end of the sequence, consisting of the trinucleotide NGG. Upon successful 
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targeting of Cas9 (mediated by a guide RNA), it introduces a DSB 3 bp upstream of the PAM 
site. Such a DSB may trigger non-homologous end joining (NHEJ), which is an error prone 
repair mechanism, potentially introducing indels. Alternatively, it might trigger homology 
directed repair (HDR), which is a repair mechanism relying on a (partially) homologous 
template and can therefore be used to insert a sequence of choice (e.g. a gene tag like GFP or 
FLAG). To reduce off-target effects, two genetically modified versions of Cas9, so called 
Cas9n, can be used together to target a specific locus (Figure 9D). Cas9n only possesses 
nickase activity, so one of the enzymes nicks the sense strand, while the other one nicks the 
anti-sense strand. Since both enzymes are needed simultaneously and they are each guided by 
their own guide RNA, this strategy greatly enhances target specificity59. Another strategy to 
avoid off-target effects uses two catalytically inactive Cas9 enzymes, that have a FokI 
nuclease domain attached (fCas9, Figure 9E). In order to cause a DSB, two FokI domains 
need to dimerize, which happens only if two fCas9s bind DNA in close proximity60.  
 
1.3.2.2 RNA interference 
RNAi is probably the easiest and most straight forward method to do reverse genetic screens. 
Unlike targeted mutagenesis, it’s very much feasible for large scale screens. It was discovered 
in C. elegans61 and since then, a myriad of phenotypes could be analyzed based on gene 
knock-down experiments, where a transcript of choice gets depleted. By doing so, functional 
studies of genes were carried out in various organisms, including C. elegans, Drosophila, 
human cells and Planaria. RNAi is an endogenous gene silencing mechanism, where double-
stranded RNA (dsRNA) targets messenger RNAs (mRNAs) of the same or similar sequence 
for degradation, cleavage or translational repression61,62. Whole genome RNAi libraries are 
available for several organisms, which enables silencing of most genes and thereby allows 
genome-wide loss-of-function-screens (Figure 10). 
28 
 
 
Figure 10. Overview of RNAi screening approaches used in different organisms. In C. elegans, RNAi is 
applied through dsRNA-expressing bacteria that are fed to the worms. In contrast, Drosophila cells are loaded 
with dsRNA by bathing. In both cases, the dsRNA is intracellularly processed and diced into small-interfering 
RNAs (siRNAs), which leads to a highly efficient knock-down, as several different siRNAs are generated from 
one molecule of dsRNA. In humans and other vertebrates, introduction of siRNA requires transfection. Usually 
several independent siRNAs targeting the same gene are used simultaneously to ensure a proper knock-down. 
Alternative methods include viral transfection of hairpin expressing constructs, which get processed by dicer in 
vivo and endoribonuclease-derived siRNAs (esiRNAs), which are generated from dsRNA in vitro using an 
enzyme such as RNAse III or dicer. RISC: RNA-induced silencing complex; T7: bacteriophage T7 promoter; 
Image by Boutros and Ahringer.63 
 
RNAi libraries usually rely on the siRNA pathway, because siRNAs are specific to one target 
gene only. Besides the siRNA pathway, there is also a micro RNA (miRNA) pathway. Both 
siRNA and miRNA have similar physiochemical properties, but they have distinct functions 
and a different mechanism to trigger gene silencing (Table 1).  
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Table 1. Comparison of siRNA and miRNA 
 siRNA miRNA 
Before being processed 
by Dicer 
30 to over 100 nucleotides of dsRNA 70 to 100 nucleotides of precursor 
miRNA (pre-miRNA) with interspersed 
mismatches and hairpin structure 
Structure 21-23 nucleotide RNA duplex with 2 
nucleotides 3’ overhang 
19-25 nucleotide RNA duplex with 2 
nucleotides 3’ overhang 
Complementarity Fully complementary to target mRNA Partially complementary to target 
mRNA(s), typically targeting the 3’ 
UTR 
mRNA target one several (could be over 100) 
Silencing mechanism Endonucleolytic cleavage of mRNA Translational repression; Degradation of 
mRNA; Endonucleolytic cleavage of 
mRNA (rare, only for high 
complementarity) 
 
Essentially, both of them are processed by Dicer and loaded into the RISC complex, but 
siRNAs have a single target only with a 100% sequence homology to a certain mRNA that 
gets cleaved, while miRNAs can have several targets with a <100% sequence homology and 
targeted mRNAs get either cleaved, degraded or their translation gets repressed.   
It’s important to mention here that in C. elegans, the primary RNAi response is enhanced by a 
secondary RNAi mechanism, which happens both up- and downstream of the initial dsRNA 
trigger64–66. The mechanism relies on RNA-dependent RNA polymerases (e.g. RRF-1 and 
EGO-1), that are recruited onto target mRNAs and synthesize secondary siRNAs that greatly 
increase the overall RNAi effectiveness. Secondary siRNAs are more abundant than primary 
siRNAs and associate with worm-specific Argonautes (WAGOs), which results in mRNA 
decay and co-transcriptional silencing (Figure 11). 
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Figure 11 Primary and 
secondary RNAi responses for 
both exogenous and 
endogenous RNAi pathways. 
Red indicates the RDE-10/RDE-
11 complex and other proteins 
that are required for the 
accumulation of a subset of 
WAGO class 22G siRNAs;  
Blue indicates primary siRNAs, 
their precursors, and interacting 
Argonautes;  
Green indicates secondary 
siRNAs, their precursors, and 
interacting Argonautes. 
Image by Zhang et al.67 
 
 
 
 
 
 
To apply RNAi in C. elegans, there are basically three different methods: injection, soaking 
and feeding68. The least labor intensive and cheapest method is feeding worms on bacteria 
that produce the desired dsRNA and, for that reason, it is also by far the most practiced 
method in C. elegans laboratories69. Results are a bit more variable than with the other two 
methods, but it is very reasonable to treat a large number of worms, both on solid or in liquid 
culture. Bacterial clones can be easily accessed from two major RNAi libraries. The Ahringer 
library was generated by cloning gene-specific genomic fragments between two inverted T7 
promoters, thus containing both introns and exons70,71. It consists of 19762 clones, with an 
additional supplementary library of 3507 clones72. The Vidal library was generated by 
Gateway cloning of full-length open reading frame (ORF) cDNAs into a double T7 vector73 
and consists of 11511 clones, which target 10953 genes74.  
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Generally, both forward and reverse genetic screens were, and still are, very powerful tools to 
get valuable insight as to how genes function and to gather information on what molecular 
events underlie a certain biological process. 
 
1.4 Forward genetic screens targeted at isolating cell lineage mutants identified 
members of LINC complexes in C. elegans 
Forward genetic screens that have been done in model organisms like Drosophila or C. 
elegans, contributed a lot to the initial insights into nucleo-cytoskeletal coupling LINC 
(Linker of Nucleoskeleton and Cytoskeleton) complexes. Genes that were identified in 
screens for a specific phenotype were often much later linked to other phenotypes, molecular 
pathways or protein networks. For instance, the SUN1 ortholog UNC-84 was already 
identified in 198075, but its identity as a SUN-domain protein was described almost 20 years 
later in 199976.  
LINC complexes and especially the UNC-83/UNC-84 LINC complex are being discussed in 
the following sections. 
 
1.4.1 LINC complexes 
The nuclear lamina is connected to the cytoskeleton via different ‘Linker of Nucleoskeleton 
and Cytoskeleton’ (LINC) complexes with a variety of functions. LINC complexes are widely 
conserved over various phyla, which include organisms such as plants, slime molds, yeast, 
roundworms, fruit flies and mammals. LINC complexes cross the nuclear membrane and are 
composed of SUN and KASH domain-containing proteins, which interact in the perinuclear 
space between the inner and outer nuclear membrane. KASH proteins are located at the outer 
nuclear membrane and may interact with actin filaments, microtubules (via dynein and 
kinesin), intermediate filaments (via spectrin), centrosomes and other cytoplasmic organelles. 
SUN proteins are located at the inner nuclear membrane and are associated with both 
chromatin and nuclear lamins. Functions include nuclear movement and anchoring, moving 
meiotic chromosomes and telomeres and sensing mechanic stimuli7–10. 
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1.4.2 The UNC-83/UNC-84 LINC complex 
Both the KASH domain gene unc-83 and the SUN domain gene unc-84 have been identified 
in a forward genetics EMS screen in the early eighties75. The screen aimed to identify mutants 
with alterations of the normally invariant post-embryonic cell lineage. The initially observed 
phenotype for both unc-83 and unc-84 mutant animals was identical, namely a lower amount 
of nuclei in the ventral nerve cord as compared to WT animals. Interestingly, all seven mutant 
isolates of unc-83 and unc-84 were temperature sensitive, showing a more penetrant 
phenotype at elevated temperatures (25 °C instead of 20 °C or 15 °C)77. Sulston and Horvitz 
could link the lack of neuronal nuclei in the ventral nerve cord to a defect in P cell migration, 
which was temperature dependent. Mutant animals with a deficient ventral nerve cord 
displayed difficulties moving backwards (Unc phenotype). In addition, they found that unc-83 
and unc-84 were required for the migration of certain hypodermal nuclei. During the 
embryonic development of the syncytial hypodermis, as well as during the postembryonic 
development of the ventral cord, certain cells develop protrusions superficial to body wall 
muscles. In WT animals, nuclei move along these protrusions. They observed that in unc-83 
or unc-84 mutants, although these protrusions form normally, nuclei failed to move. 
  
Figure 12. Nuclear migration defects in unc-
84 mutant animals. The graphic illustrates two 
different kinds of nuclear migration defects in 
unc-84 mutant animals. (A) The process of six 
out of 17 hyp7 precursor cells undergoing cell 
elongation and nuclear migration are 
representatively shown. WT embryo is shown 
on top, unc-84 mutant embryo at the bottom. 
The migration defect of the mutant is 
temperature independent. (B) P cell nuclear 
migration of one out of 12 P cells is shown.  
WT larva is shown on top, unc-84 mutant larva 
at the bottom. The migration defect of the 
mutant is temperature dependent (normal 
migration at 15 °C, impaired migration at 25 
°C). Anterior is to the left, ventral is 
downward. Image by Malone et al.76. 
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Furthermore they describe how only the movements of two specific classes of hypodermal 
nuclei are affected by mutations in either unc-83 or unc-84. After the initial isolation of those 
mutants, it took almost 20 years to shed some additional light on the subcellular localization 
and function of unc-8476. Malone and colleagues found out that UNC-84 localizes to the 
nuclear envelope and that it has a predicted transmembrane domain. Furthermore they 
describe migration defects of hyp7 precursor and P cells in more detail (Figure 12). While 
nuclear migration defects are present in both unc-83 and unc-84 mutants, they reported that 
unc-84 mutants additionally show a nuclear anchoring defect in the hyp7 syncytium, 
suggesting that besides its role in nuclear migration, UNC-84 exhibits also a role in nuclear 
anchoring.  
The lab of Daniel A. Starr confirmed these findings and identified the KASH domain of 
UNC-83, which enables binding to the SUN domain of UNC-8478,79. Together these two 
proteins form a LINC complex and cross the nuclear membrane, thus linking the cytoskeleton 
with the nuclear lamina. There are several other proteins involved that directly or indirectly 
bind to UNC-83, including NUD-2, LIS-1, DLC-1, BICD-1, EGAL-1, KLC-2 and UNC-116 
(Figure 13). NUD-2/LIS-1 and DLC-1/BICD-1/EGAL-1 are two dynein-regulating complexes 
that get recruited by UNC-83. Besides dynein, UNC-83 also interacts with a second 
microtubule motor: kinesin-1. It consists of a heavy chain (UNC-116) and a light chain (KLC-
2). Both microtubule motors have a distinct role in nuclear migration, as the Starr lab has 
shown in follow up analyses80–82. During embryonic hyp7 precursor nuclear migration, 
kinesin-1 is the major force that drives nuclei forward (towards the plus end of polarized 
microtubule), while dynein is responsible for bidirectional movements. Upon cytoplasmic 
roadblocks, dynein is able to move nuclei backwards for short stretches in order to bypass 
them (nuclear rolling). In contrast, during larval P-cell migration, dynein is the major force to 
move nuclei towards the minus end of microtubules. At the late L1 stage, P cells move to the 
ventral cord and the ventral surface is covered by the hyp7 syncytium. For this to happen, P-
cell nuclei need to migrate from a lateral to a ventral position through a constricted space 
between body wall muscles and the cuticle. The constricted space is about 200 nm in width, 
which is about 5% of the pre-migration diameter of the nucleus. Failure of P-cell nuclear 
migration leads to Egl (egg laying deficient) and Unc (uncoordinated) animals due to the lack 
of certain vulval cells and motor neurons that originate from P-cells. 
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Figure 13. The UNC-83/UNC-84 LINC complex. UNC-84 is localized to the inner nuclear membrane (INM) 
and UNC-83 to the outer nuclear membrane (ONM).The KASH domain (pink) of UNC-83 interacts with the 
SUN domain (red) of UNC-84 in the perinuclear space. The cytoplasmic part of UNC-83 (green) interacts with 
the light chain of kinesin-1 (KLC-2, dark blue). The motor activity of the kinesin-1 heavy chain (UNC-116, light 
blue) moves nuclei toward the plus end of microtubules (yellow). UNC-83 also interacts with two dynein 
regulating complexes, NUD-2/LIS-1 (shades of purple) and DLC-1/EGAL-1/BICD-1 (shades of pink) which 
recruit motor dynein to the nuclear envelope to move the nucleus towards the minus-end of microtubules.  
Image by Fridolfsson et al.79 
 
1.5 Reverse genetics identified reprogramming barriers in C. elegans 
C. elegans is a powerful model organism to identify and study reprogramming barriers in 
vivo. The chromatin regulator LIN-53 (CAF-1p48/RBB7) for instance, was identified in C. 
elegans as a reprogramming barrier for the transdifferentiation of germ cells to neuron- and 
muscle-like cells in a reversed genetics screen83,84. Subsequently, the mouse ortholog of LIN-
53, CAF-1, was shown to act as a reprogramming barrier in reprogramming somatic cells to 
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iPS cells85, confirming the potential of using C. elegans as a system to identify evolutionary 
conserved reprogramming barriers.   
Other reprogramming barriers that we have identified in our lab include HMG-3/4 and SPT-
16, which form the FACT complex. 
 
1.5.1 FACT (FAcilitates Chromatin Transcription) complex 
FACT is a conserved heterodimeric complex composed of two subunits: SUPT16H 
(suppressor of Ty 16 homolog) and SSRP1 (structure-specific recognition protein 1) in 
mammals, Spt16 and Pob3 in yeast, as well as SPT-16 and HMG-3 or HMG-4 in C. 
elegans1,86,87. It is essential for maintaining stable gene expression by promoting transcription 
and functions by disrupting histone-DNA and histone-histone interactions, thus reorganizing 
nucleosomes. Besides its role in transcription, it was also shown to be involved in DNA 
repair88 and replication89–91. It also promotes the integrity of chromatin structure on a genome-
wide level, for instance, by suppressing cryptic transcription87,92.   
In a genome-wide reverse genetic RNAi screen in the nematode C. elegans, we identified 
FACT as a barrier for TF-mediated transdifferentiation1 (Figure 14). We discovered that 
FACT in C. elegans exists in two different variants: one is germline-specific and consists of 
SPT-16 and HMG-3, while the other is predominantly somatic and consists of SPT-16 and 
HMG-4. FACT is required to maintain the germline and intestinal fate in C. elegans. 
Strikingly, its role as a reprogramming barrier is conserved, as its depletion enhances the 
reprogramming of human fibroblasts into iPSCs and neurons.  
Identifying FACT as a reprogramming barrier was unexpected, because it is known as a 
positive regulator of gene expression, and previously described reprogramming barriers 
typically act as gene repressors93. Examples include the histone chaperone LIN-53 in C. 
elegans83,84 (RBBP4/CAF-1P48 in mammals, section 1.4.2) and the Chromatin Assembly 
Factor 1 (CAF-1) in mice85. They promote gene silencing by introducing repressive chromatin 
marks, thereby blocking cell fate reprogramming. FACT is the first reported complex that 
promotes gene expression and still acts as a reprogramming barrier. Upon FACT depletion in 
human fibroblasts, the expression of many genes goes down, but some FACT-occupied genes 
show increased expression levels, suggesting that FACT might also have repressive functions. 
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Its combined role in promoting gene expression and preventing chromatin binding 
accessibility of certain TFs seems to be conserved in worms and humans and might be 
essential to maintain a specific cell fate program in both species.  
Figure 14. FACT as a 
reprogramming barrier 
in C. elegans and H. 
sapiens. The FACT 
complex consists of two 
different subunits. In C. 
elegans, there are two 
distinct variants, one which 
is germline specific, the 
other is somatic. It 
safeguards cell identities 
and acts as a 
reprogramming barrier in 
both C. elegans and human 
cell culture. Image by 
Kolundžić et al.1. 
 
 
 
 
1.6 Pseudogenes 
Pseudogenes are DNA loci that share a sequence homology with a parental gene, but have lost 
some or all of their functionality94,95. There are several ways how pseudogenes can evolve, for 
instance, a non-essential gene might accumulate mutations that render it nonfunctional, but it 
can also happen through copy number variations, where DNA segments are duplicated or 
deleted. Although pseudogenes lost (some) functionality, they can still be functional, even if 
they aren’t translated, and might perform regulatory functions similar to other kinds of 
noncoding RNA. In fact, many pseudogenes play a role in normal physiology and pathology 
such as cancer96.  
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The two main characteristics that constitute a pseudogene are sequence homology to a 
parental gene and loss of some functionality. The former means that the parental gene and 
pseudogene diverged from a common ancestral sequence, while the latter characteristic means 
that any of the steps of proper gene expression, usually transcription, pre-mRNA processing, 
translation, and protein folding, is altered in a way that the original function of the gene is lost 
or changed. The most common reason for this would be a premature stop codon or a 
frameshift, which would prevent translation into a functional protein.  
There are four different main types of pseudogenes: processed, non-processed, unitary and 
pseudo-pseudogenes.  
• Processed (or retrotransposed) pseudogenes exist only in higher eukaryotes, especially 
mammals, as they originate from retrotransposition. Retrotransposition is the process of 
mRNA (or pre-mRNA) getting spontaneously reverse transcribed to DNA and being 
subsequently inserted into the genome97,98. They are typically characterized by a poly-A 
stretch at the 3’ end (as a result of the poly-A tail of the original mRNA) and also by the lack 
of introns and a promoter.  
• Non-processed (or duplicated) pseudogenes originate from a gene duplication event with the 
subsequent acquirement of mutations that would make the pseudogene lose its original 
function. Gene duplication might happen through homologous recombination, for example at 
repetitive sequences of misaligned chromosomes99. Non-processed pseudogenes usually share 
many characteristics with the parental gene like regulatory sequences or an intact exon-intron 
structure. Evolutionary gene duplications generate redundancy, and since the organism just 
needs one intact gene, mutations in the other would not affect its fitness. Since there is no 
natural selection on one of the copies, it gradually acquires mutations over time and 
transforms into a pseudogene.   
• Unitary pseudogenes are the result of various mutations (such as indels or nonsense 
mutations) that would render a gene less- or non-functional, similar to non-processed 
pseudogenes. In contrast to non-processed pseudogenes, there was no gene duplication event 
prior to pseudogenization, and, as a consequence, the parental gene is lost. One example of a 
unitary pseudogene is the gene that encodes L-gulono-γ-lactone oxidase (GULO). In non-
primate animals, GULO usually aids in the biosynthesis of ascorbic acid, but in humans and 
other primates, only a non-functional pseudogene variant of the gene, termed GULOP, 
exists100.  
• Pseudo-pseudogenes are genes that were originally classified as pseudogenes because of the 
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appearance of a premature stop codon in a mRNA sequence. Due to translational read-
through, such a stop codon might be skipped and a small amount of functional protein might 
be produced101,102.  
 
Figure 15. An overview of pseudogene functions. Pseudogenes might influence the parental gene (A-E), have 
functions unrelated to the mother gene (F-H) or may affect another gene (I-J).  Image by Poliseno et al.103 
Pseudogenes can be functional in many different ways103 (Figure 15). For instance, the 
parental gene might get epigenetically silenced by sense or antisense transcripts of the 
pseudogene. Sense and antisense transcripts of the pseudogene might form dsRNA that gets 
cleaved into siRNAs and can downregulate the parental gene post-transcriptionally. Sense 
transcripts of the pseudogene might compete with the parental mRNA for the binding of 
microRNAs, RNA-binding proteins or the translational machinery (‘sponging’).   
There are many other mechanisms that have been described of how a pseudogene can have a 
biological function. The interested reader might have a closer look at Figure 15 or might want 
to learn something about F55A3.7, a pseudogene that resembles an important part of this 
thesis and is introduced in the next section.    
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1.6.1 F55A3.7 is a pseudogene related to spt-16 
F55A3.7 is a previously uncharacterized pseudogene in very close proximity to its parental 
gene, the FACT subcomponent encoding gene spt-16. It is shorter than spt-16, oriented in the 
opposite direction less than 2 kb afar (Figure 16A) and shares a sequence homology of more 
than 90% with its parental gene (Figure 16B). Based on our data, F55A3.7 gets spliced and 
consists of four exons, so it’s likely that it is a non-processed pseudogene rather than a 
processed one. There is a complex substitution allele available, F55A3.7(ok1829), which is a 
1342 bp deletion with a 2 bp insertion spanning the second and third exon (Figure 16A).   
 
 
 
Figure 16. The pseudogene F55A3.7 and its parental gene spt-16. (A) F55A3.7 consists of four exons, is 
shorter than spt-16 and oriented in the opposite direction less than 2 kb away. The ok1829 allele is a variant, 
where a part of the sequence of the second exon and the whole sequence of the third exon are deleted. (B) Both 
the genomic and the spliced sequence of spt-16 are highly similar to the genomic and spliced sequence of 
F55A3.7, based on a NCBI nucleotide blast.     
We found that upon broad CHE-1 induction, F55A3.7(ok1829) mutant animals show a similar 
gcy-5p::gfp induction in germ cells as upon FACT depletion based on hmg-3 RNAi (Figure 17 
and Section 1.4.3). In F1 RNAi experiments, about 30% of F55A3.7(ok1829) animals 
displayed the gcy-5p::gfp induction phenotype (Figure 17A,B). Morphological changes like 
the shape of converted germ cell nuclei and the axo-dendridic like projections of gcy-5p::gfp 
A 
B 
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positive cells suggest a similar robust reprogramming, as we could show with the depletion of 
the FACT member hmg-31 (Figure 17C and Section 1.4.3).  
 
 
Figure 17. The pseudogene F55A3.7 and its germ cells to neurons conversion phenotype upon depletion 
and broad CHE-1 overexpression. (A) F1 generation larvae (L4 state) of control animals (BAT28) and 
F55A3.7(ok1829) animals (BAT372) were quantified. Error bars represent SEM. (B) Representative image of 
GFP induction in the germline of F55A3.7(ok1829) mutant animals. Scale bar, 50 µm. (C) Converted germ cells 
underwent morphological changes. They lost their characteristic fried egg shaped nuclear morphology and 
adopted a speckled neuronal nuclear morphology (left) and, furthermore, displayed axo-dendritic-like projections 
(right). Dashed lines indicate the outline of gonads, dashed boxes indicate the magnification. Scale bars, 10 µm. 
Image by Ena Kolundžić104. 
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1.7 Aim of this thesis 
One aim of this thesis was to identify and characterize genetic factors that play a role in 
induced transdifferentiation by mis-expressing the TF HLH-1, which is the worm homolog of 
the myogenic bHLH TF MyoD. When mis-expressed, HLH-1 induces the muscle fate in early 
embryonic cells, but terminally differentiated cells in older animals are resistant to HLH-1-
induced direct reprogramming. In order to identify mechanisms that antagonize HLH-1-
induced reprogramming in ectopic tissues, I used a transgenic line allowing ectopic 
expression of the hlh-1 gene in combination with a reporter for muscle fate (myo-
3p::gfp::NLS). To do so, I developed a semi-automated high-throughput forward genetic 
screen combining EMS mutagenesis with the Biosorter system (Union Biometrica). Using this 
approach, I identified a mutant showing additional cells at the posterior end of the pharynx 
that expressed the myo-3 reporter. I identified the mutated locus using whole genome 
sequencing and characterized the identified gene and the mutant phenotype further.  
Additionally, I was also involved in characterizing the FACT complex, which was identified 
through a whole-genome RNAi screen conducted by my colleague Ena Kolundžić1. This 
reverse genetic screen, in contrast to the forward genetic screen that I performed, aimed at 
identifying factors that play a role in induced transdifferentiation by mis-expressing the TF 
CHE-1, a Zn-finger TF essential for terminal differentiation of glutamatergic ASE neurons. 
Interestingly, one of the FACT complex members, spt-16, is the parental gene of a previously 
uncharacterized pseudogene named F55A3.7. A putative null mutant of F55A3.7, combined 
with broad overexpression of CHE-1, showed a germ cells to neurons transdifferentiation 
phenotype similar to the phenotype observed after depleting the FACT member hmg-3. To our 
knowledge, this is the first example of a pseudogene whose depletion leads to the 
permissiveness of a certain tissue to be reprogrammed when challenged by a terminal selector 
TF. Due to this uniqueness, my aim was to characterize the pseudogene F55A3.7 and to find a 
potential mechanism for how F55A3.7 safeguards germline identity. 
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2 Results 
 
2.1 A forward genetic screen reveals the requirement of the LINC member UNC-83 
during positioning of body wall muscle nuclei in C. elegans 
My initial aim was to identify and characterize genetic factors that play a role in induced 
transdifferentiation by mis-expressing the TF HLH-1, which is the worm homolog of the 
myogenic bHLH TF MyoD. When mis-expressed, HLH-1 induces muscle fate in early 
embryonic cells, but terminally differentiated cells in older animals are resistant to HLH-1-
induced direct reprogramming. In order to identify mechanisms that antagonize HLH-1 
induced reprogramming in ectopic tissues, I used a transgenic line allowing ectopic 
expression of the hlh-1 gene in combination with a reporter for muscle fate, the transcriptional 
myosin reporter myo-3p::gfp::NLS (Figure 18A). To do so, I developed a semi-automated 
high-throughput forward genetic screen combining EMS mutagenesis with the Biosorter 
system (Union Biometrica, Figure 18B). Using this approach, I identified a mutant showing 
additional GFP-signals based on a myo-3 reporter at the posterior end of the pharynx and 
named the mutant allele bar18 (Figure 18C). 
 
2.1.1 Additional muscle nuclei around the posterior pharyngeal bulb in bar18 mutant 
animals are independent of ectopic hlh-1 induction 
With the initial semi-automated high-throughput EMS screen (Figure 18), I isolated BAT173, 
a strain containing a heat-shock inducible hlh-1 transgene (hsp-16.2::hlh-1), a transcriptional 
myosin reporter for muscle fate (myo-3p::gfp::NLS) and the EMS induced bar18 mutation. 
Since the phenotype of additional GFP positive nuclei around the posterior pharyngeal bulb 
was heat-shock independent and could be observed at different temperatures (15°, 20° and 25 
°C), I outcrossed the hlh-1 transgene using WT N2 worms to generate BAT197 (ccls4251 
[myo-3p::gfp::NLS], bar18) which was used for further characterization. The independence of 
the phenotype from ectopic hlh-1 induction already suggested that the mutated gene might not 
be a reprogramming barrier of induced transdifferentiation, but was causing a kind of 
developmental lineage defect. 
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Figure 18. The mutant bar18 was isolated by a semi-automated high-throughput EMS screen. (A) In a WT 
situation, myo-3 active cells (green) can be found already in early embryonic stages and in adult worms (left). 
When an early embryo is challenged by ectopic HLH-1 expression, most cells will transdifferentiate into muscle 
like cells, unlike in adults, where cells are less plastic and inhibitory mechanisms safeguard the identity of 
already differentiated cells (middle). Upon removal of such inhibitory mechanisms by EMS mutagenesis, 
terminally differentiated cells in adult worms might also be reprogrammed to muscle like cells (right). (B) The 
BioSorter is a continuous flow system capable of analyzing and sorting 10-20 worms per second based on 
fluorescent intensity. (C) Compared to WT worms (left), bar18 mutants (right) display an accumulation of body 
wall muscle nuclei around the posterior pharyngeal bulb (area indicated by dashed boxes). (NLS) nuclear 
localization signal; Anterior is to the left. 
 
2.1.2 Whole-genome sequencing in conjunction with a SNP Mapping Strategy revealed 
that the mutated locus belongs to unc-83 
To identify the locus that was affected by the bar18 mutation, I used whole-genome 
sequencing in conjunction with a SNP Mapping Strategy105 and a published CloudMap 
pipeline106. The principle is simple: I crossed the bar18 mutant with a polymorphic C. elegans 
strain, the Hawaiian WT strain CB485, selected individual F2 progeny animals that showed 
the bar18 phenotype and allowed them to self-fertilize. The F3 generations were pooled and 
submitted to whole-genome sequencing (WGS). The region of the phenotype-causing 
sequence variant had a lower density of polymorphic SNP markers and could therefore be 
identified in the WGS data. By doing so, I identified a premature STOP in the KASH-domain-
containing gene unc-83 (Figure 19A,B).  
EMS 
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To test whether this mutation was causing the observed phenotype of accumulating body wall 
muscle nuclei around the posterior pharyngeal bulb, I performed rescue experiments, driving 
WT unc-83 from an extrachromosomal array either under the control of the muscle-specific 
promoter myo-3p or the ubiquitous promoter eft-3p (Figure 19C, 20). Providing WT unc-83 in 
the mutant background rescues the phenotype, thus confirming the identity of bar18 as the 
premature STOP-causing mutation of unc-83.  
 
Figure 19. The bar18 mutation causes a premature STOP in unc-83 and has a cell autonomous effect on 
body wall muscle nuclei positioning. (A) Hawaiian SNP distribution reveals the position of bar18 on 
chromosome V (see text for details). (B) Genome browser screenshot of WGS reads at a specific spot of the unc-
83 gene. A C>T conversion in bar18 animals causes a premature STOP within the coding region of the gene. (C) 
Fluorescent images showing GFP-positive body wall muscle nuclei in WT (BAT661), unc-83(bar18) mutant 
(BAT1298, without the extrachromosomal rescue construct barEx453) and unc-83(bar18) mutant rescue animals 
(BAT1298, with the extrachromosomal rescue construct barEx453, driving WT unc-83 from the muscle-specific 
promoter myo-3p). In the rescued animal, the pharynx expresses myo-2p::mCherry which is marking transgenic 
animals carrying barEx453. Dashed boxes highlight the area around the posterior pharyngeal bulb, where nuclei 
accumulate in the mutant. Anterior is to the left. 
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2.1.3 The accumulation of muscle nuclei around the posterior pharyngeal bulb in unc-
83(bar18) mutant animals is a cell autonomous effect 
Since driving WT unc-83 from either the eft-3 or myo-3 promoter rescues the phenotype, I 
could not only confirm that the phenotype-causing mutation bar18 indeed affects unc-83, but 
could also show that the effect is cell autonomous. Furthermore, I could phenocopy the 
accumulation of body wall muscle nuclei around the posterior pharyngeal bulb using a 
previously published unc-83(ku18) premature STOP allele (Figure 20). In addition, I tested 
the unc-84(e1174) deletion allele, which also shows this phenotype, supporting the 
assumption that a non-functioning UNC-83/UNC-84 LINC complex is responsible for the 
mis-positioning of muscle nuclei.  
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Figure 20. Different unc-83/unc-84 alleles show the same phenotype of accumulating body wall muscle 
nuclei around the posterior pharyngeal bulb. (A) Phenotype penetrance of body wall muscle nuclei mis-
positioning in WT (BAT661), unc-83(bar18) mutant (BAT197), unc-83(ku18) mutant (BAT1980), unc-84(e1174) 
mutant (BAT968), unc-83(bar18) muscle-specific rescued (BAT1298, BAT1906, BAT1907) and unc-83(bar18) 
ubiquitously rescued (BAT1300, BAT1908, BAT1909) animals. n ≥300 for each sample; 3 biological repeats; 
Error bars represent SEM. (B) Summary of unc-83/84 alleles used in this study. Image adapted from genome 
browser of www.wormbase.org 
 
2.1.4 Accumulated nuclei around the posterior pharyngeal bulb in unc-83(bar18) 
animals are not due to an overall increase in the amount of muscle cells 
I quantified the amount of GFP-positive muscle nuclei in WT and unc-83(bar18) worms at 
different larval stages using the reporter construct rrrSi261 [myo-3p::gfp::H2B] (in contrast 
to the reporter described above, a single copy of rrrSi261 is integrated into the genome 
thereby making it very dim, but more stable without any tendency for mosaicism). 
Surprisingly, the overall number of GFP-positive cells remained unchanged for all larval 
stages (Figure 21). At L1 stage, I counted 78.5 vs. 78.6 nuclei, at L3 stage I counted 94.7 vs. 
94.6 nuclei and at L4 I counted 106.6 vs. 105.3 nuclei in unc-83(bar18) or WT animals, 
respectively. These results are comparable with previously reported numbers of muscle 
cells13: C. elegans has an invariant number of somatic cells, including 95 striated body wall 
muscles from the L2 stage onwards (81 in L1) and several other non-striated muscles, some of 
which are born at later larval stages.   
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Figure 21. Amount of GFP-positive nuclei (excluding sex muscles) in WT (BAT1488) and unc-83(bar18) 
mutant (BAT1099) animals at the larval stages L1, L3 and L4. For L1 and L3 stages, these are exclusively 
body wall muscle cells. For the L4 stage, nuclei of other myo-3p::gfp::NLS-positive muscles, like somatic sheath 
or enteric muscles, contribute to the overall number of counted nuclei. n ≥10 for each condition; n.s. = not 
significant according to a student’s t-test (p >0.05) between WT and mutant; Error bars represent SEM. 
 
2.1.5 The UNC-83/UNC-84 LINC complex is required for proper body wall muscle 
nuclei positioning in C. elegans 
Since the accumulation of muscle nuclei around the second pharyngeal bulb is not due to an 
increased number of muscle nuclei, it must be a positioning defect. In order to quantify the 
defect of body wall muscle nuclei in unc-83(bar18) animals, I sub-divided animals into 3 
different regions (head, neck, posterior body) and quantified the amount of body wall muscle 
nuclei in WT and unc-83(bar18) animals (Figure 22). The neck region was defined as the 
region between the anterior pharyngeal bulb and the first pair of intestinal nuclei. The anterior 
region was defined as head and posterior was defined as posterior body. Overall, unc-
83(bar18) animals displayed 36.1% less nuclei in the head region (7.8 vs. 12.3), 28.7% more 
nuclei at the neck region (28.3 vs. 22.0) and 3.1% less nuclei in the posterior body region 
(58.5 vs. 60.3) compared to WT animals. Our findings suggest that the nuclei accumulating in 
the neck region of unc-83 mutants originate primarily from the head region. 
Figure 22. unc-83(bar18) animals display a positioning defect of body wall muscle nuclei. (A) Differential 
interference contrast (DIC) microscopic image of a L3 worm. The defined areas head (anterior part of the worm 
until after anterior pharyngeal bulb), neck (end of head region until after first pair of intestinal nuclei) and 
posterior body (end of neck region until posterior end of the worm) are highlighted. The differences in body wall 
muscle nuclei numbers between WT (BAT1488) and unc-83(bar18) mutant (BAT1099) worms are shown (based 
on the values shown in B).  
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(B) Distribution of body wall muscle nuclei in WT (BAT1488) and unc-83(bar18) mutant (BAT1099) L3 
animals. There is no significant difference for the total number of body wall muscle nuclei. For the head and 
posterior body region, mutant animals display reduced amounts of body wall muscle nuclei, while the number of 
nuclei in the neck region is increased. Statistical significance based on student’s t-test. n =12 for each condition; 
*p ≤0.02, ***p ≤0.0001; Error bars represent SEM. 
In summary, I describe a so far uncharacterized phenotype of mis-positioned body wall 
muscle nuclei upon lack of a functioning UNC-83/UNC-84 LINC complex in C. elegans. 
Animals having mutations in unc-83/84 display an accumulation of body wall muscle nuclei 
around the posterior pharyngeal bulb. The phenotype of unc-83(bar18) animals can be 
rescued by driving WT unc-83 from either a muscle specific myo-3 promoter or a ubiquitous 
eft-3 promoter. My data suggests that this cell autonomous effect is primarily due to nuclei 
that are displaced from the head of the worm towards the neck region. Overall, these findings 
broaden our current understanding of this ubiquitously expressed LINC complex in C. 
elegans, which was so far described to ensure proper nuclei positioning in P cells, the 
intestine and hyp7 hypodermal precursors, but not for muscle tissue. 
 
2.1.6 Mutations of the LINC members unc-83 and unc-84 cause motility defects in C. 
elegans  
As already outlined in the introduction, Sulston and Horvitz identified a temperature 
dependent Unc phenotype of unc-83 or unc-84 mutant animals that displayed difficulties 
moving backwards. This phenotype could be linked to a defect in P cell migration and the 
resulting reduction of neurons in the ventral nerve cord, which was more penetrant at elevated 
temperatures (25 °C instead of 20 °C or 15 °C)77. Since the positioning defect of muscle 
nuclei that I identified in unc-83 and unc-84 deficient animals is temperature independent, I 
was interested to see whether mutant animals would display any other motility defects, 
besides the difficulties of moving backwards at elevated temperatures, that I could link to this 
muscle specific phenotype.  
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Figure 23. Motility assays. (A) An exploration assay measures exploration behavior based on movement across 
a bacterial lawn that has a grid applied to it107. Image taken from Flavell et al.107. (B) A swimming assay 
measures the amount of body bends an animal is doing while swimming in a droplet of liquid for 30 seconds. 
Videos are analyzed automatically using the ImageJ plugin wrMTrck108.  
I made use of two different assays to test this and did all experiments at 15 °C to uncouple any 
potential outcome from a lack of ventral nerve cord neurons due to impaired P cell migration. 
An exploration assay measures the motility based on movement across a bacterial lawn 
overnight (Figure 23A), while a swimming assay measures the body bends a worm is 
performing while being in a droplet of liquid (Figure 23B).  
Both unc-83(bar18) and unc-84(e1174) animals performed worse than WT animals in an 
exploration assay (Figure 24). Compared to WT animals, who visited 2,83 squares/h on 
average, unc-83(bar18) animals visited 2,40 squares/h, while unc-84(e1174) animals visited 
only 2,26 squares/h. Interestingly, the impaired exploration behavior couldn’t be rescued 
neither by driving WT unc-83 from a muscle specific myo-3 promoter (2,15 squares/h), nor 
from a ubiquitous eft-3 promoter (2,32 squares/h, Figure 24).  
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Figure 24. LINC deficient animals show decreased exploration behavior compared to WT animals. While 
WT animals explored 2,83 squares/h on average, both unc-83(bar18) and unc-84(e1174) explored significantly 
less squares. This phenotype couldn’t be rescued neither by driving WT unc-83 from a muscle specific myo-3 
promoter, nor from a ubiquitous eft-3 promoter in an unc-83(bar18) background. WT animals visited 
significantly more squares than any of the other tested strains, while all other strains except WT showed no 
significant difference in their exploration behavior. n ≥39 for each condition. ***: p<0,01; n.s.: not significant.    
To complement the exploration assays which measure long turn movements over a period of 
~16 h, I performed swimming assays which measure short turn movements over a period of 
30 sec (Figure 25). Like in the exploration assays, unc-83(bar18) animals showed an impaired 
movement compared to WT animals (1,57 body bends/sec vs. 2,03 in WT) and this defect 
could not be rescued by driving WT unc-83 under the control of the muscle specific myo-3 
promoter (1,68 body bends/sec). In contrast to the exploration assays, driving WT unc-83 
from the ubiquitous eft-3 promoter could fully rescue mutant animals in swimming assays 
(2,21 body bends/sec) that showed no significant difference to WT animal movements.  
In summary, I could demonstrate so far uncharacterized motility defects of UNC-83 deficient 
animals at 15 °C, besides the already published impaired backward movements at elevated 
temperatures77, using exploration and swimming assays. Two rescue lines, one driving WT 
unc-83 from a muscle specific myo-3 promoter and the other driving it from a ubiquitous eft-3 
promoter, could rescue the nuclei positioning defect in muscle cells (Figure 19C, 20A), but 
fail to rescue the exploration behavioral defects (Figure 24), suggesting that the exploration 
behavioral defect is not linked to mis-positioned nuclei in muscle cells. Motility defects 
identified by swimming assays were still present in the myo-3p rescue line, but were fully 
recued in the eft-3p rescue line (Figure 25), suggesting that the mechanisms of impaired 
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exploration and swimming are different and that the latter one might be connected to a tissue 
other than muscle (e.g. neurons).  
Figure 25. UNC-83 deficient animals show an impaired swimming behavior as compared to WT animals. 
WT animals show significantly more body bends/sec as unc-83(bar18) or myo-3p rescued animals. Driving WT 
unc-83 from the ubiquitous eft-3 promoter fully rescues the motility defect of unc-83(bar18) animals. n ≥25 for 
each condition. ***: p<0,01; n.s.: not significant.     
 
2.1.7 Lack of the LINC member UNC-83 shortens the life span of C. elegans 
I was interested to see whether the unc-83(bar18) mutation would cause other physiological 
phenotypes besides those that have been published previously (see section 1.3.2) and the 
positioning defect of muscle nuclei that I discovered10. One physiological defect that I could 
link to UNC-83 deficient animals was a shorter life span as compared to WT animals (Figure 
26). Animals were kept at 15 °C until the late L4 stage to avoid defects in P cell 
migration76,78,79 and were then put on plates containing 5-Fluoro-2′-deoxyuridine (FUDR) and 
shifted to 20 °C (see methods part for details). While WT animals displayed an average life 
span of 20,5 days, unc-83(bar18) mutants only lived for 16,6 days on average. Interestingly, 
driving WT unc-83 from neither the muscle-specific promoter myo-3p nor from the ubiquitous 
promoter eft-3p could completely rescue the short life span phenotype, however, both rescue 
lines still showed a significant partial rescue (Figure 26). 
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Figure 26. Mutants with a deficient UNC-83 show a decreased life span. While WT animals (blue line) had 
an average life span of 20,5 days, unc-83(bar18) mutants (green line) only lived 16,6 days on average. Driving 
an intact unc-83 from a muscle specific myo-3p (yellow line) or a ubiquitous eft-3p (orange line), could only 
partially rescue the short life span (18,3 and 17,9 days respectively). 90 animals per condition, 3 biological 
replicates. P-values: WT vs. unc-83(bar18): p ≤ 0,01; unc-83(bar18) vs. unc-83(bar18), myo-3p::unc-83: p ≤ 
0,01, unc-83(bar18) vs. unc-83(bar18), eft-3p::unc-83 = p ≤ 0,02. Data analyzed using OASIS 2109. 
In order to see if the life span reducing effect of unc-83(bar18) was linked to the daf-2 
pathway, or to dietary restriction, which are both known to be involved in aging 
regulation110,111, I tested the impact of two age-prolonging mutations on life span in a WT and 
unc-83(bar18) mutant background: age-1(hx564) (daf-2 pathway, Figure 27) and eat-
2(ad465) (dietary restriction, Figure 28). Both mutations increased the average life span of 
WT animals to a similar amount as they did in unc-83(bar18) animals (Figure 27, 28). WT 
animals lived 22,9 days on average when having the age-1(hx564) mutation (instead of 20,5 
days, ≙ +11,7%), while unc-83(bar18) animals lived 18,7 days on average when having the 
age-1(hx564) mutation (instead of 16,6 days ≙ +12,7%; Figure 27). The eat-2(ad465) 
mutation increased the average lifespan of WT animals from 20,5 to 27,7 days (+35,1%), 
while it increased it from 16,6 to 24,2 days for unc-83(bar18) animals (+45,8%; Figure 28).   
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Figure 27. The life extending mutation age-1(hx564) increases the life span of UNC-83 deficient animals to 
a similar amount, as it does in WT animals. Having the age-1(hx564) mutation in a WT background (yellow 
line) significantly increases the average life by 11,7% as compared to WT (blue line), while having it in an unc-
83(bar18) mutant background (orange line) significantly increases the average life span by 12,7% as compared 
to having the unc-83(bar18) mutation only (green line). 90 animals per condition, 3 biological replicates. P-
values of all conditions: p ≤ 0,01; Data analyzed using OASIS 2109. 
 
The life-shortening effect of unc-83(bar18) only partially suppresses the life-prolonging 
effects of age-1(hx564) and eat-2(ad465), and both mutations extend the life span in a similar 
way as they do in WT worms, which suggests that they act independently of each other (they 
are non-epistatic to one another). My results support the hypothesis that the effect of lacking 
UNC-83 on C. elegans’ life-span is unrelated to both the daf-2 pathway and to dietary 
restriction.    
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Figure 28. The life extending mutation eat-2(hx564) increases the life span of UNC-83 deficient animals to 
a similar amount, as it does in WT animals. Having the eat-2(ad465) mutation in a WT background (yellow 
line) significantly increases the average life by 35,1% as compared to WT (blue line), while having it in an unc-
83(bar18) mutant background (orange line) significantly increases the average life span by 45,8% as compared 
to having the unc-83(bar18) mutation only (green line). 90 animals per condition, 3 biological replicates. P-
values of all conditions: p ≤ 0,01; Data analyzed using OASIS 2109. 
2.1.8 A HLH-1::tagRFP fusion protein is actively degraded by the proteasome in C. 
elegans 
We were wondering why my initial forward genetic screen, which aimed to identify genes that 
inhibit direct reprogramming of differentiated cells into muscle-like cells, did not yield any 
such candidates. The only mutant I could isolate showed an accumulation of muscle nuclei 
around the posterior pharyngeal bulb, a phenotype that turned out to be independent of any 
hlh-1 induction. HLH-1 is a TF that specifies muscle cells during embryogenesis and is being 
maintained in muscle tissue throughout larval development and adulthood. One idea that came 
to our mind was that maybe HLH-1 protein has a high turn-over rate and needs constant 
transcription because it’s being degraded in vivo. To test this hypothesis, I generated a 
translational reporter line that expresses a HLH-1::tagRFP fusion protein under the control of 
a heat-shock promoter. Upon heat-shocking animals for 6 h at 32 °C, the protein is clearly 
visible under a fluorescent microscope, but the signal is lost after keeping the animals at 25 
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°C O/N (Figure 29A), suggesting that HLH-1::tagRFP proteins get degraded. I repeated the 
experiment, but killed the worms after the 6 h heat-shock and before shifting them to 25 °C 
O/N. The tagRFP signal was still visible the next morning, indicating that the protein gets 
actively degraded in vivo, but does not degrade in vitro (Figure 29B). One canonical pathway 
of protein degradation is working through the ubiquitin-proteasome system112, so we looked 
up the C. elegans genes that would encode for proteins that make up the catalytic center of the 
16s proteasome subunit (pbs-3 and pbs-6, Figure 29C).  
 
Figure 29. HLH-1::tagRFP is actively degraded by the ubiquitin-proteasome system. (A) HLH-1::tagRFP 
translational reporter expression right after a 6 h heat-shock treatment at 32 °C (left) and after an additional O/N 
incubation at 25 °C (right). (B) Light microscopic (top) and fluorescent (bottom) images of three C. elegans hlh-
1::tagRFP reporter corpses. Worms were killed after a 6 h heat-shock treatment at 32 °C. Pictures were taken 
after an additional O/N incubation at 25 °C. (C) 16s Proteasome subunit. The C. elegans homologue genes 
encoding for the catalytic center (red) are shown. Image adapted from Beck et al.113 (D) Quantification of HLH-
1::tagRFP fluorescent signals of the reporter strain shown in A and B, after heat-shock treatment and O/N 
incubation as in A and B, treated with EV control RNAi, pbs-3 RNAi and pbs-6 RNAi. n ≥ 60.      
PBS-3 
PBS-6 
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I repeated the experiment another time, treating worms either with a control RNAi (empty 
vector, EV) or with RNAi against the proteasome genes pbs-3 or pbs-6 (Figure 29D). 
Knocking down either pbs-3 or pbs-6 could preserve the HLH-1::tagRFP signal, arguing that 
HLH-1 gets actively degraded by the ubiquitin-proteasome system.  
This fact might be the reason why I didn’t identify any reprogramming barriers in my forward 
genetic screen, as HLH-1, the TF needed to specify muscle fate, seems to get degraded too 
rapidly. In order to screen for reprogramming barriers that would prevent induced 
transdifferentiation into a muscle lineage, it might be needed to use a promoter that would 
ensure constant expression of hlh-1 in later developmental stages, but would not be active in 
early embryos, in favor of a heat-shock promoter.  
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2.2 A reverse genetic screen identifies members of FACT and the pseudogene F55A3.7 
as barriers of induced germ cell to neuron conversion in C. elegans 
As already outlined in the introduction (section 1.5.1),  we identified the FACT complex in C. 
elegans as a reprogramming barrier for the transdifferentiation of germ and intestinal cells to 
neurons1. The human orthologues of the two FACT subunits are SUPTH16 (SPT-16 in C. 
elegans) and SSRP1 (HMG-3 or HMG-4 in C. elegans; Figure 30A). Interestingly, SSRP1 has 
two different orthologues, HMG-3 and HMG-4, which originated from a gene duplication. We 
were interested to explore if they would have distinct functions in C. elegans. An RNAi 
knock-down of hmg-3 enables germ cells to be reprogrammed to neurons, while an hmg-4 
knock-down enables intestinal cells to be reprogrammed to neurons, upon broad che-1 
induction. Due to this fact, we thought about the possibility that hmg-3 and hmg-4 might be 
expressed in a tissue specific manner. While for SPT-16, there was an antibody available, no 
specific antibodies for HMG-3 or HMG-4 existed. Therefore, I HA-tagged both of these genes 
using CRISPR/Cas9, and indeed, they are differentially expressed. HMG-3::HA could only be 
detected in the germline (Figure 30B), HMG-4::HA could predominantly be detected in the 
soma (Figure 30C), while SPT-16 is ubiquitously expressed (Figure 30D). We therefore 
concluded that SPT-16/HMG-3 FACT safeguards cell identity in the germline, while SPT-
16/HMG-4 safeguards cell identity in the intestine (Figure 30E).   
While the existence of the two FACT subunits HMG-3 and HMG-4 is the consequence of a 
gene duplication resulting in two functional proteins with distinct expression patterns, a gene 
duplication of the FACT subunit SPT-16 resulted in the pseudogene F55A3.7. It consists of 
four exons and is shorter than its mother gene spt-16. It is oriented in the opposite direction of 
spt-16 less than 2 kb away. A deletion allele spanning the second and third exon is also 
available (Figure 16A). We found that upon broad CHE-1 induction, mutant animals with the 
deletion allele F55A3.7(ok1829) show a similar germ cell to neuron reprogramming 
phenotype as upon FACT depletion based on hmg-3 RNAi (section 1.4.3). Morphological 
changes like the shape of converted germ cell nuclei and the axo-dendridic like projections of 
gcy-5p::gfp positive cells suggest a robust reprogramming (Figure 17). To our knowledge, 
this is the first example of a pseudogene whose depletion leads to the permissiveness of a 
certain tissue to be reprogrammed when challenged by a terminal selector TF and thus I 
characterized the pseudogene F55A3.7 and tried to find a potential mechanism for how 
F55A3.7 safeguards germline identity. 
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Figure 30. Subunits and expression patterns of FACT in C. elegans. (A) Models of FACT subunits in H. 
sapiens and C. elegans. Conserved protein domains according to Pfam (pfam.xfam.org) and InterPro 
(ebi.ac.uk/interpro) are indicated. (B) Immunostaining of CRISPR-tagged HMG-3::HA. (C) Immunostaining of 
CRISPR-tagged HMG-4::HA. (D) Immunostaining of SPT-16. (E) Model of how tissue-specific FACT isoforms 
prevent induction of neuronal genes in the germline and intestine. Dashed lines indicate the outline of the 
animals. Scale bars represent 20 μm. 
 
2.2.1 The pseudogene F55A3.7 is being transcribed and spliced  
To test whether there is a F55A3.7 transcript being made in the C. elegans germline, I 
dissected gonads from both WT (BAT1753) and F55A3.7(ok1829) worms (BAT1749), 
isolated RNA and reverse transcribed it into cDNA. I designed primers that I could also use 
for qRT experiments (section 2.2.3), not only for F55A3.7, but also for spt-16 and hmg-3.  
59 
 
Figure 31. F55A3.7 is being transcribed and spliced. (A) RT-PCR using WT gonadal (left) or 
F55A3.7(ok1829) mutant (right) RNA as template. Tested genes are indicated. Red boxes mark the F55A3.7 
band or the lack thereof. (B) We amplified the estimated four exons containing full length cDNA transcript 
(1708bp), which was subsequently subjected to Sanger sequencing.   
 
All primer pairs give a band of the expected size, and there was no band for F55A3.7 in the 
F55A3.7(ok1829) mutant (Figure 31A). Primers for F55A3.7 span parts of the third and fourth 
exon. Additionally, we amplified the estimated full-length cDNA transcript and sent it to 
Sanger sequencing, thus confirming our predicted intron/exon borders (Figure 31B). 
 
2.2.2 F55A3.7 RNA is not translated into a protein 
To explore the possibility that despite a proper open reading frame (ORF), a small amount of 
functional protein might be produced from F55A3.7 RNA due to translational read-through 
(section 1.5), I tagged the endogenous F55A3.7 locus with a FLAG epitope using 
CRISPR/Cas9 editing (Figure 32A). Immunofluorescent staining using an anti-FLAG 
antibody did not show any signal, unlike the positive control, where I used a strain that 
expressed LMN-1::FLAG with a nuclear localization signal under the control of the muscle-
specific reporter myo-3p (Figure 32B).    
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Figure 32. Immunostaining and Western blot of F55A3.7::FLAG worm lysates. (A) Using CRISPR/Cas9 
gene-editing, a 3xFLAG-tag was introduced at the C-terminal end of endogenous F55A3.7. (B) 
F55A3.7::3xFLAG worm lysates did not show any FLAG staining (BAT1594, upper left), while the LMN-
1::2xFLAG positive control did (BAT1468, lower left). DAPI images to the right. (C) Western blot with N2 
(negative control), HIS-71::2xFLAG (BAT748, positive control) and F55A3.7::3xFLAG worm lysates stained 
for FLAG. A positive band for F55A3.7::3xFLAG would have been expected at 24,3 kDa. 
Western blot experiments confirmed my results from the immunostainings, as F55A3.7 
showed no band (it would have been expected at ~24 kDa), while the positive control for 
FLAG tagged HIS-71 showed the expected band at ~17 kDa (Figure 32C). 
 
2.2.3 F55A3.7 ncRNA does not affect mRNA and protein levels of its mother gene spt-
16, nor those of hmg-3 or lin-53  
The simplest explanation for the germline conversion phenotype that we experienced in the 
F55A3.7(ok1829) mutant background (Figure 17) upon broad CHE-1 expression, would be a 
direct influence of F55A3.7 ncRNA on transcript or protein levels of its mother gene spt-16. 
To explore this possibility, I performed qRT-PCR of dissected gonads to check for germline-
specific transcript levels of spt-16 in a WT and F55A3.7(ok1829) mutant background, and 
additionally also for the FACT member hmg-3 and the histone chaperone lin-53, which are 
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both also known to cause the same germline conversion phenotype upon knock-down (section 
1.4). However, germ-line specific transcript levels of spt-16, hmg-3 and lin-53 were unaltered 
in F55A3.7(ok1829) mutant animals (Figure 33A). 
Figure 33. Gonad specific transcript and whole worm protein levels of WT and F55A3.7(ok1829) mutant 
animals for spt-16, hmg-3 and lin-53. (A) Gonadal lysates of WT (BAT1753) and F55A3.7(ok1829) mutant 
(BAT1749) animals tested with qRT-PCR for transcript levels of spt-16, hmg-3 and lin-53. 3 biological repeats 
with 3 technical repeats each. Error bars represent SD. n.s.: not significant (B) Western blot of whole worm 
lysates of WT (BAT1753) and F55A3.7(ok1829) mutant (BAT1749) animals. α -Tubulin was stained as loading 
control after stripping the membrane.  
My qRT-PCR results could be supported by western blots, with the only difference that staged 
young adults were lysed instead of dissected gonads due to higher need of input material. We 
could show that SPT-16, HMG-3::HA and LIN-53 protein levels were the same in WT and 
F55A3.7(ok1829) mutant animals (Figure 33B), suggesting that the ncRNA F55A3.7 is acting 
through other mechanisms to prevent the permissiveness of germ-cells to be reprogrammed 
into neurons upon che-1 induction.  
 
2.2.4 F55A3.7 ncRNA acts in trans 
Given the close vicinity of the F55A3.7 locus to its mother gene spt-16 (Figure 19A), we 
wanted to exclude that the germ cell to neuron conversion phenotype caused by che-1 
overexpression in conjunction with the F55A3.7(ok1829) deletion allele was an effect in cis, 
acting on spt-16. Our qRT-PCR and Western blot data already argue against this possibility, 
but we still also wanted to make sure that active transcription of F55A3.7 is needed for it to 
fulfill its function and that the phenotype we observe is not due to an enhancer element that 
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got deleted in ok1829. In order to test this, I created three recue lines that express WT 
F55A3.7 from an extrachromosomal array in the F55A3.7(ok1829) mutant background. The 
strains also have the heat-shock inducible che-1 construct and the gcy-5p::gfp neuronal 
reporter. After inducing che-1 by heat-shock in L4 animals, I scored them the next day for the 
germ line conversion phenotype (Figure 34). For all three lines the phenotype penetrance was 
reduced to less than 50% of the phenotype penetrance of the F55A3.7(ok1829) control strain 
without any recue construct. This partial rescue demonstrates that F55A3.7 ncRNA acts in 
trans, as it represses the phenotype even when being transcribed from a different locus. Taken 
together, our data suggests that F55A3.7 is being transcribed but not translated and that it acts 
as an ncRNA in trans, independently of spt-16, hmg-3 or lin-53.        
 
Figure 34. Relative phenotype 
penetrance of CHE-1 induced 
germ cells to neurons 
reprogramming in 
F55A3.7(ok1829) mutant 
strains with and without a 
recue construct. Red bar: 
control strain without rescue 
construct (BAT372). Green 
bars: recue strains with rescue 
construct (BAT1956, BAT1957, 
BAT1959). n = 44 – 124 per 
condition; ***: p<0,01  
 
 
2.2.5 Gonad specific RNA-seq and ATAC-seq reveal many up- and downregulated loci 
In order to identify a potential mechanism of how the non-coding RNA F55A3.7 safeguards 
germ cell identity, we performed germline-specific RNA sequencing (RNA-seq; Figure 35) 
and a germline-specific Assay for Transposase Accessible Chromatin with high-throughput 
sequencing (ATAC-seq; Figure 36). To do so, we manually dissected gonads and isolated 
RNA and DNA samples that were subjected to library preparation and sequencing.   
RNA-seq uses next-generation sequencing (NGS) to both qualitatively and quantitatively 
identify RNA in a biological sample. After library preparation (Figure 35A), which includes 
transcribing RNAs into cDNAs and barcoding samples specifically, the transcriptome of WT 
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(N2) and F55A3.7(ok1829) (RB1524) gonads were sequenced using a NGS Illumina 
sequencer. Samples were done in triplicates, using 20 gonads per sample. One replicate of 
F55A3.7(ok1829) needed to be dropped, since it didn’t pass our quality control due to low 
sequencing coverage. For the other samples we got, on average, between six and eight million 
reads per replicate (Figure 35B). N2 control replicates cluster together in a principle 
component analysis (PCA), as do the F55A3.7(ok1829) replicates (Figure 35C) and we could 
identify several significantly differentially expressed genes between these two groups (Figure 
35D).  
Figure 35. Gonad specific RNA-seq of WT (N2) and F55A3.7(ok1829) (RB1524) animals. (A) Library 
preparation included fragmentation, rRNA depletion, reverse transcription / first strand synthesis, second strand 
synthesis, A-tailing, adapter ligation and PCR amplification (see material and methods for details). (B) We 
generated between 6 and 8 million reads per replicate. (C) PCA analysis of WT (N2) vs. F55A3.7(ok1829) 
(RB1524) samples. (D) Differentially expressed genes between WT (N2) and F55A3.7(ok1829) (RB1524) 
gonads. 
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In addition to RNA-seq, we performed gonad specific ATAC-seq, profiling the epigenetic 
landscape of DNA extracted from WT (N2) and F55A3.7(ok1829) (RB1524) mutant gonads 
(Figure 36A). The technique makes use of a mutant hyperactive Tn5 transposase, which cuts 
exposed open DNA and simultaneously ligates specific adapter sequences to it. Adapter-
ligated DNA fragments are then isolated, amplified by PCR and used for NGS114,115. 
Triplicates were very similar to each other, but very different between F55A3.7(ok1829) 
sample and N2 control groups (Figure 36B). In general, F55A3.7(ok1829) gonadal DNA 
displayed a more closed chromatin state as compared to N2 DNA, with 4668 loci that were 
more closed, while only 1063 loci were more open. The loci that were more closed in the 
F55A3.7(ok1829) background were found mostly in promoter regions (97,13%), with the 
majority of ATAC reads being less than 1 kb from the TSS (86,09%; Figure 36C). In contrast, 
loci that were more open in the F55A3.7(ok1829) background were less likely to be in 
Promoter regions (74,05%) and also further away from the TSS on average with only 41,03% 
of loci being within 1 kb of the TSS (Figure 36D).   
Figure 36 Gonad specific ATAC-seq of WT (N2) and F55A3.7(ok1829) (RB1524) animals. (A) A mutant 
hyperactive Tn5 transposase cuts open DNA regions and simultaneously adds adapter sequences that can be later 
sequenced with NGS. (B) Heat map of chromatin state similarity between different sequenced samples. (C) 
Localization of downregulated loci of F55A3.7(ok1829) gonadal DNA as compared to WT DNA. (D) 
Localization of upregulated loci of F55A3.7(ok1829) gonadal DNA as compared to WT DNA.   
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I was looking for overlaps of our RNA-seq and ATAC-seq data sets and compared 
significantly (p ≤ 0,1) up-regulated and down-regulated genes that displayed a 
log2FoldChange ≥ [1,33] (RNA-seq) or a Fold ≥ [1,33] (ATAC-seq). I could find 9 genes that 
were up-regulated in both data sets (Figure 37A, Table 2) and 12 genes that were down-
regulated in both data sets (Figure 37B, Table 2). Furthermore, I compared our data for down-
regulated genes with a set of genes that we previously identified as potential reprogramming 
barriers of induced transdifferentiation into a neuronal lineage by a genome-wide RNAi 
screen1. Doing so, I identified two overlapping genes with our RNA-seq data, including 
F55A3.7 itself, which was expected and can be seen as a positive control of our approach. 
Furthermore, 34 genes were overlapping with our ATAC-seq data (Figure 37C, Table 3). 
F55A3.7 down-regulation in the RNA-seq data is shown as an example in Figure 37D.  
  
 
Figure 37. Cross comparisons of RNA-seq and ATAC-seq data of F55A3.7 depleted worms amongst each 
other and with a set of previously identified potential reprogramming barriers from a genome-wide RNAi 
screen. (A) Venn diagram of upregulated genes of F55A3.7(ok1829) gonads in comparison to WT gonads for 
RNA-seq and ATAC-seq. (B) Venn diagram like in A for downregulated genes. (C) Venn diagram like in B, 
overlapped with potential reprogramming barriers identified by a genome-wide RNAi screen1. (D) F55A3.7 
down-regulation in RNA-seq. P ≤ 0,1 log2FoldChange (RNA-seq)  ≥ [1,33];  Fold (ATAC-seq) ≥ [1,33]. 
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Table 2. Overlap of RNA-seq and ATAC-seq data of F55A3.7 depleted worms.  
Upregulated genes colored in green, downregulated ones in red. 
Gene Name Gene biotype Log2FoldChange 
(RNA-seq) 
p-value 
(RNA-seq) 
Chrom. Fold 
(ATAC-seq) 
p-value 
(ATAC-seq) 
Y47G6A.31 protein_coding -4,53 2,74E-02 I -1,65 5,14E-11 
gbb-1 protein_coding -3,62 4,01E-04 X -2,15 1,58E-15 
fbxc-43 protein_coding -3,49 1,29E-02 II -1,63 6,5E-08 
his-43 protein_coding -3,36 7,77E-10 II -1,66 0,0303 
fmo-5 protein_coding -3,13 1,04E-02 V -1,8 3,13E-14 
unc-51 protein_coding -2,86 3,75E-02 V -2,54 6,84E-18 
unc-63 protein_coding -2,43 9,65E-02 I -1,78 8,1E-09 
K07F5.12 protein_coding -2,25 2,17E-02 IV -1,76 3,91E-11 
fbxa-217 pseudogene -2,16 3,65E-02 I -1,75 1,89E-09 
CE7X_3.1 pseudogene -2,15 2,92E-02 X -1,55 2,22E-07 
haf-6 protein_coding -1,68 3,50E-04 I -2,28 3,33E-19 
bath-19 protein_coding -1,34 4,62E-02 II -1,53 6,96E-07 
sydn-1 protein_coding 1,41 4,87E-02 I 3,38 2,39E-14 
Y48G1C.5 protein_coding 2,92 8,95E-02 I 1,68 8,54E-08 
abt-5 protein_coding 3,00 7,03E-02 I 2,95 8,22E-12 
best-19 protein_coding 3,36 3,46E-03 IV 1,68 1,25E-09 
Y32F6A.6 pseudogene 3,36 8,41E-02 V 1,96 6,23E-11 
M162.7 protein_coding 3,40 9,09E-02 V 4,85 4,21E-55 
Y43F8C.5 protein_coding 3,57 3,23E-02 V 2,93 1,25E-22 
mlc-7 protein_coding 3,74 4,26E-02 III 1,59 5,24E-09 
B0545.4 protein_coding 5,18 1,47E-02 IV 3,22 5,52E-22 
 
Together, our sets of overlapping genes (Figure 37A-C) will be the basis of an 
enhancer/suppressor screen, where I will try to identify genes that upon knock-down of the 
respective candidate in the F55A3.7(ok1829) mutant background, would enhance or suppress 
the reprogramming efficiency of a germ cell to neuron conversion upon induction of CHE-1. 
This strategy might help to dissect the molecular mechanism of how F55A3.7 RNA protects 
germline identity in C. elegans. 
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Table 3. Overlap of RNA-seq and ATAC-seq data of F55A3.7 depleted worms with potential 
reprogramming barriers from a genome-wide RNAi screen1.   
gcy-5p::gfp induction of the genome wide RNA screen depicted in %, affected tissues indicated by 
abbreviations: GeCo: Germline Conversion, GuCo: Gut Conversion, MuCo: Muscle Conversion, EpCo: 
Epidermis Conversion. 
Gene Name Gene biotype gcy-5p::gfp induction Chrom. Fold 
(ATAC-seq) 
p-value 
(ATAC-seq) GeCo GuCo MuCo EpCo Other 
cox-5A protein_coding 0 50 0 0 0 III -2,77 2,26E-24 
Y39B6A.3 protein_coding 0 10 0 0 0 V -2,74 3,14E-28 
afd-1 protein_coding 10 0 10 0 0 I -2,43 2,81E-17 
imb-3 protein_coding 10 0 0 0 0 I -2,42 7,06E-16 
eel-1 protein_coding 10 0 0 0 0 IV -2,36 1,36E-15 
mrg-1 protein_coding 30 0 0 0 0 III -2,28 2,62E-14 
ogdh-1 protein_coding 10 30 0 10 0 IV -2,15 4,76E-18 
lig-1 protein_coding 15 0 0 0 0 V -2,14 2,35E-11 
ucr-1 protein_coding 0 25 0 0 0 III -2,13 1,56E-15 
cdk-9 protein_coding 5 30 0 0 0 I -2,1 3,00E-14 
lpd-5 protein_coding 0 10 0 0 0 I -2,02 3,38E-16 
gfm-1 protein_coding 0 30 0 0 0 II -2,01 1,88E-15 
F23H11.5 protein_coding 0 35 0 0 0 III -1,97 4,44E-13 
R119.5 protein_coding 15 0 0 0 0 I -1,92 1,04E-09 
vha-1 protein_coding 10 0 0 10 0 III -1,87 7,95E-11 
C11H1.3 protein_coding 15 0 0 0 0 X -1,86 1,80E-07 
C34C12.8 protein_coding 0 40 0 0 0 III -1,77 1,39E-11 
C07F11.2 protein_coding 5 0 0 0 0 I -1,72 4,98E-10 
fah-1 protein_coding 0 60 0 0 0 X -1,66 1,12E-06 
dlst-1 protein_coding 0 20 0 0 0 V -1,65 4,72E-09 
F38A1.8 protein_coding 0 50 0 0 0 IV -1,61 6,58E-10 
bud-31 protein_coding 10 0 0 0 0 III -1,6 2,53E-08 
spg-7 protein_coding 30 30 0 0 0 I -1,59 2,61E-07 
Y54E5A.5 protein_coding 15 10 0 0 0 I -1,58 8,43E-09 
cox-5B protein_coding 15 15 0 0 0 I -1,57 3,06E-07 
div-1 protein_coding 15 0 0 0 0 III -1,57 1,53E-08 
Y82E9BR.3 protein_coding 0 50 0 0 0 III -1,57 1,98E-07 
act-4 protein_coding 15 0 0 0 10 X -1,53 5,43E-07 
hmg-4 protein_coding 0 60 0 0 0 III -1,49 5,87E-07 
tba-2 protein_coding 10 0 0 0 0 I -1,48 6,79E-07 
psf-3 protein_coding 10 0 0 0 0 I -1,48 4,57E-06 
pafo-1 protein_coding 0 40 0 0 0 V -1,45 3,97E-08 
dnj-11 protein_coding 15 0 0 0 0 IV -1,41 1,56E-06 
Gene Name Gene biotype gcy-5p::gfp induction Chrom. Log2Fold
Change 
(RNA-seq) 
p-value 
(RNA-seq) 
GeCo GuCo MuCo EpCo Other 
his-12 protein_coding 0 20 0 0 0 II -2,80 6,19E-04 
F55A3.7 pseudogene 0 60 0 0 0 I -3,04 9,28E-05 
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3 Discussion 
In a semi-automated high-throughput forward genetic screen I isolated the mutant bar18, 
showing an accumulation of muscle cell nuclei around the posterior pharyngeal bulb of the 
worm due to a positioning defect. WGS revealed that bar18 animals carry a mutation in the 
KASH-domain gene unc-83 causing a premature STOP. An additional unc-83 mutant allele 
recapitulates the phenotype, as does a mutant allele of UNC-84, a SUN-domain containing 
protein that interacts with UNC-83. UNC-83 and UNC-84 belong to a LINC complex that 
bridges the nuclear lamina with the cytoskeleton. Additionally, I could identify several other 
phenotypes that are connected to a lack of the UNC-83/UNC-84 LINC complex, which have 
not been described so far: a shorter life span and an impaired exploration and swimming 
behavior.  
Beside developing this screen and analyzing unc-83(bar18), I was also involved in 
characterizing the FACT complex, which was identified through a whole-genome RNAi 
screen1. Interestingly, one of the FACT complex members, spt-16, is the parental gene of a 
previously uncharacterized pseudogene named F55A3.7. A putative null mutant of F55A3.7, 
combined with broad overexpression of CHE-1, showed a germ cells to neurons 
transdifferentiation phenotype similar to the phenotype observed after depleting the FACT 
member hmg-3.  
In this chapter I am going to discuss the differences between forward and reverse genetics, 
based also on the two screens that I am describing in this thesis. Furthermore, naturally, the 
results and potential future steps will be discussed. 
3.1 Forward vs. reverse genetic screens 
As already outlined in the introduction, C. elegans is highly amenable to genetic screens due 
to its short generation time, its hermaphroditic lifestyle and ease of use for both mutagenesis 
and RNAi knock-down experiments. While my colleague Ena Kolundžić did a reverse 
genetics genome wide RNAi screen and identified more than 150 reprogramming barrier 
candidates1,104, I did a forward genetic mutagenesis screen and identified only one candidate, 
that later turned out to be no reprogramming barrier (section 2.1, 3.2)10. So is reverse genetics 
superior to forward genetics? At a first glance, it might look like this is the case, but it clearly 
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isn’t, as I will outline in this section. Both approaches have their benefits as well as their 
drawbacks and, ideally, can complement each other. 
The primary reason why I didn’t identify more candidates with my semi-automated high-
throughput EMS mutagenesis screen might have been the system I used: a transgenic C. 
elegans line allowing ectopic expression of the myogenic bHLH TF MyoD homologue hlh-1 
in combination with a reporter for muscle fate, the transcriptional myosin reporter myo-
3p::gfp::NLS. The transgenic strain for the genome-wide RNAi screen allowed ectopic 
expression of the Zn-finger TF CHE-1, which is essential for terminal differentiation of 
glutamatergic ASE neurons in conjunction with the transcriptional gcy-5 neuronal reporter. 
Both strains are making use of the same heat-shock promoter (hsp-16.2p) to activate the 
respective TF. Unlike the strain for the genome-wide RNAi screen, which was already tested 
and well characterized before83, the strain I was using was untested. I only found out after 
having established the semi-automated high-throughput screen that HLH-1 is unstable in vivo 
and actively being degraded by the proteasome system (section 2.1.8). Due to the high 
turnover of HLH-1 protein, an initial burst of ectopic HLH-1 by heat-shocking the worms 
might not have been enough to trigger successful transdifferentiation, even when 
reprogramming barriers were successfully mutated by EMS. To circumvent this shortcoming 
of the system, an alternative would have been to use a reporter that would be constitutively 
active during later developmental stages to ensure a constant and stable expression of HLH-1. 
To our knowledge, such a ubiquitous promoter has not been described yet. Using an early 
ubiquitous promoter like eft-3p116 would most likely cause several still plastic cells in the 
early larvae to differentiate to muscle tissue, developmentally arresting the worms or at least 
rendering them sterile due to the resulting lack of a healthy germline. There are several tissue-
specific promoters known that are active only in later developmental stages, like col-19p117 
for epidermis or vit-5p118 for gut. This strategy would have the drawback of allowing ectopic 
expression of HLH-1 in one tissue type only, but would ensure a constant and stable 
expression of HLH-1. Another possibility would be using a system that allows temporal and 
spatial control of a gene of interest, like the FLP/FRT and Cre/lox recombination systems119 
or the split cGal system120.  
Another difficulty comes from the fact that the myo-3 muscle fate reporter necessary for this 
kind of screen is already very abundantly expressed throughout the worm, highlighting 95 
body wall muscle cells among a few others (Figure 6). An increase in the amount of muscle 
cells can therefore be hard to detect – a reason why I used the Biosorter, which can measure 
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slight changes in fluorescent patterns more precise than the human eye could. The system 
used for the genome-wide RNAi screen was based on the ASE neuron fate reporter gcy-
5::gfp, which very specifically highlights just one ASE neuron (ASER) in the head of the 
worm. Detecting ectopic GFP signals in other tissues is therefore very fast and easy.  
So the discrepancy of the amount of putative reprogramming barriers detected by the forward 
versus reverse genetic screen, is not due to an intrinsic ability or shortcoming of one of the 
two techniques, but due to the different setups used to perform the screens (hlh-1 + myo-
3p::gfp::NLS vs. che-1 + gcy-5p::gfp). However, what are intrinsic abilities or shortcomings 
of a forward genetic EMS mutagenesis screen vs. a reverse genetic RNAi screen? Probably 
the most straightforward advantage of a reverse genetic screen is the fact that a phenotype can 
immediately be connected to a gene, since the gene being knocked down to induce a certain 
phenotype is known. In a forward genetic screen, the phenotype-causing gene needs to be 
identified, which can be done with the help of whole-genome sequencing (WGS). Another 
advantage of RNAi is the possibility of doing candidate approach screens, testing just a 
predefined subset of genes. Furthermore, it enables enhancer and suppressor screens, testing a 
combination of two (or even more) genes, e.g. by using a mutant with a certain phenotype and 
combining it with RNAi or using conjugation which allows up to three genes to be knocked 
down simultaneously (Marlon Kazmierzcak et al., unpublished).   
The benefits of classical forward genetics by applying chemical mutagenesis are as manifold 
as the advantages of reversed genetics. Genes can be identified that would show a phenotype 
only after a complete knock-out and would not show it by applying RNAi, which always 
results in a partial depletion only. UNC-83, which I identified during a forward genetic EMS 
screen, is a good example. The allele I isolated contains a point mutation causing a premature 
STOP, and this putative null-allele causes muscle nuclei to be mis-positioned (section 2.1). 
Interestingly, we could not recapitulate this phenotype by applying RNAi against unc-83 in a 
WT background, but could do so using other premature STOP alleles of unc-83, indicating 
that a complete depletion of UNC-83 is needed to cause this specific phenotype. Beside 
phenotypes that require a complete knock-out rather than a knock-down of a gene, forward 
mutagenesis screens can potentially also identify gain of function alleles, e.g. by causing a 
mutation that increases transcription of a gene or a mutation that would alter post-
transcriptional regulation. Finally, mutagenesis screens might also isolate temperature 
sensitive alleles, alleles where the gene product is stable at a certain temperature, but is 
rendered nonfunctional at a specific non-permissive temperature. Such alleles enable loss of 
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function studies of genes that would, for instance, be embryonically lethal, by allowing the 
shifting of animals at a later developmental stage to the non-permissive temperature, thus 
enabling a depletion of the mutated gene product. 
Taken together, both forward and reverse genetics have several unique advantages and 
disadvantages. Depending on the scientific question, one may be chosen over the other, or it 
might even make sense to apply both for a more complementary approach. The semi-
automated high-throughput forward genetic screen I developed proofed to be very efficient, 
isolating a mutant that displayed a rather subtle phenotype, which was based only on some 
mis-positioned GFP positive nuclei that the BioSorter was able to detect. Combining the 
screen that I developed with an alternative approach to ectopically express hlh-1 (as discussed 
above) should be a very effective way of screening for factors that counteract HLH-1 induced 
transdifferentiation.   
 
3.2 A forward genetic screen aiming to find reprogramming barriers in C. elegans 
reveals something unexpected 
The beauty of forward genetics relies on the fact that it’s a rather chaotic approach, so 
unexpected outcomes can be expected. In my case I isolated the unc-83(bar18) allele, which 
we initially thought was causing an increase in the number of body wall muscle cells, since 
mutant animals displayed a strong accumulation of body wall muscle cells around the 
posterior pharyngeal bulb (Figure 19C). Following careful analysis, and quantifying the 
amount of muscle cells in WT and unc-83(bar18) mutant animals, which remained unchanged 
as compared to WT animals (Figure 21), I realized that this was not the case. Based on this 
data and due to already published information about the UNC-83/84 LINC complex (section 
1.3.2), I realized that the observed phenotype was due to a positioning defect of muscle 
nuclei, rather than a transdifferentiation event, especially since ectopic expression of the TF 
hlh-1 was not necessary to trigger that phenotype. My data suggests that this cell autonomous 
effect is primarily due to nuclei that are displaced from the head of the worm towards the neck 
region (Figure 22). An alternative explanation would be that some cells in the head region are 
missing, while some muscle cells in the neck region undergo additional cell divisions, thereby 
leading to an accumulation of nuclei (and cells) in the neck area. I think this scenario is rather 
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unlikely, since it can be explained by a similar nuclear migration mechanism that has been 
already shown for UNC-83/84 LINC in other lineages (section 1.3.2), but I cannot exclude 
that additional cell divisions might occur. 
3.3 The role of the UNC-83/UNC-84 LINC complex in C. elegans body wall muscle 
cells 
Here, I describe a so far uncharacterized role of the UNC-83/UNC-84 LINC complex in 
positioning body wall muscle nuclei in C. elegans. Animals having mutations in unc-83/unc-
84 display an accumulation of body wall muscle nuclei around the posterior pharyngeal bulb. 
The phenotype is cell autonomous, as unc-83(bar18) animals can be rescued by driving WT 
unc-83 from a muscle specific myo-3 promoter.  Using a ubiquitous eft-3 promoter rescues the 
phenotype as well.  
The reporters I used to show the nuclei mis-positioning effect in unc-83(bar18) animals are 
nuclear, so they cannot distinguish between mis-positioning of whole cells or of nuclei only. 
Since the somatic muscle tissue in C. elegans is not syncytial (unlike the epidermis), it’s likely 
that whole cells are mis-positioned, especially since this is also the case in other lineages, 
such as migrating P cells76–79. Using different reporters or immunofluorescent staining could 
potentially verify this assumption.  
What was quite interesting to see as well was the fact that accumulating nuclei around the 
second pharyngeal bulb originated mostly from the head region and not the posterior body, 
although the latter accommodates way more nuclei than the head region (Figure 22). It might 
be that the UNC-83/UNC84 LINC complex is mostly active in those muscle cells and not so 
much in others. Alternatively, it could also very likely be that the mis-positioning is a result of 
a general absence of this LINC complex and the phenotype is of passive nature, resulting 
from physical restraints and arrangements of striated body wall muscles to contribute forming 
the outer tube of the worm.  
One interesting aspect of the role of the UNC-83/UNC-84 LINC complex in muscle cells is 
the absence of a strong and obvious phenotype connected to it. In contrast, mis-positioned P 
cells for instance undergo apoptosis, which results in a lack of neurons in the ventral nerve 
cord (section 1.3.2), as well as impaired backwards movements as a secondary effect thereof. 
While this is mostly happening at elevated temperatures (25 °C), I could describe additional 
Unc phenotypes using exploration and swimming assays, which were carried out at 15 °C. 
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However, the Unc phenotypes seem to be mostly independent from the mis-positioned muscle 
nuclei phenotype. Both myo-3p and eft-3p rescue lines fail to rescue the exploration 
behavioral defect, suggesting that it is not linked to mis-positioned nuclei in muscle cells 
(since the mis-positioning phenotype is rescued in both lines, see Figure 19C, 20A). This 
could be due to a copy number issue of the rescue constructs and the exact expression levels 
of unc-83 might would need a certain fine tuning to match WT expression levels (there might 
very likely be an overexpression of UNC-83 protein in the rescue lines). In contrast to the 
impaired exploration behavior, impaired swimming could be fully rescued by driving WT 
unc-83 from the ubiquitous eft-3 promoter, but not from the muscle specific myo-3 promoter 
(Figure 25). This result suggests that that a lack of UNC-83 in a tissue other than muscle is 
responsible for this phenotype or, alternatively, a combination of muscle and another tissue. 
  
Besides the effect of lacking UNC-83 on motility, I also analyzed the effect it has on C. 
elegans’ life span and could detect a shorter life span of UNC-83 deficient animals as 
compared to WT animals (Figure 26 ). Interestingly, neither driving WT unc-83 from the 
muscle specific promoter myo-3p nor from the ubiquitous promoter eft-3p could fully rescue 
the short life span phenotype, but both rescue lines still showed a significant partial rescue 
(Figure 26). The absence of a full rescue could be a copy number issue as discussed for the 
motility assays. Furthermore, these results support a model where the lifespan decrease is 
linked to an absence of the UNC-83/84 LINC complex specifically in muscle tissue, since 
driving the rescue construct from the ubiquitous eft-3 promoter doesn’t further increase the 
amount of rescue as compared to using the muscle-specific myo-3 promoter. The exact 
mechanism of the lifespan shortening remains to be determined, but there have been studies 
already that connect LINC complexes to premature aging and disease121,122. I generated unc-
83 and age-1 as well as unc-83 and eat-2 double mutants to test in lifespan experiments. My 
results (Figure 27, 28) support the hypothesis that the effect of lacking UNC-83 on C. 
elegans’ life-span is unrelated to both the daf-2 pathway and to dietary restriction. 
Taken together, I could identify several phenotypes that are connected to a lack of the UNC-
83/UNC-84 LINC complex, which have not been described so far: mis-positioned body wall 
muscle nuclei, a shorter life span, impaired exploration and swimming behavior. Also, 
phenotypes related to muscle tissue have not been described in this context yet (only for P 
cells, the intestine and hyp7 hypodermal precursors) and it might very likely be that in the 
future other novel phenotypes will be connected to the UNC-83/UNC-84 LINC complex, 
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especially since it is ubiquitously expressed throughout the worm and also due to the fact that 
mis-positioned nuclei might work upstream of, and thereby affect many, other processes. 
 
3.4 The ncRNA F55A3.7 does not affect its mother gene spt-16 and acts in trans to 
protect germline fate  
In contrast to the UNC-83/UNC-84 LINC complex, the FACT complex in C. elegans, 
consisting of SPT-16 and either HMG-3 or HMG-4, is not ubiquitously expressed. Using 
CRISPR/Cas9 gene editing to introduce HA-tags to both HMG-3 and HMG-4 in conjunction 
with immunostaining, I could show that HMG-3 is exclusively present in the germline and 
HMG-4 is predominantly present in the soma, confirming our hypothesis that two alternative 
FACT complexes exist in C. elegans: one soma- and one germline-specific (Figure 30). While 
in the case of hmg-3 and hmg-4 a gene duplication resulted in two functional proteins with 
distinct expression patterns, a gene duplication of the FACT subunit spt-16 resulted in the 
non-translated pseudogene F55A3.7.   
I could show that the non-coding RNA F55A3.7 does not directly influence its mother gene 
and FACT member spt-16, performing both qRT-PCR and Western blots of F55A3.7(ok1829) 
mutant and control worms (Figure 33). The qRT-PCR experiments were performed with 
dissected gonads, while for Western blots, staged L4 worms were used. F55A3.7 ncRNA 
regulating spt-16 expression would have been the simplest explanation for the germline 
conversion phenotype that we experienced in the F55A3.7(ok1829) mutant background upon 
broad CHE-1 expression (Figure 17). However, our data suggests that F55A3.7 is acting 
through other mechanisms to block the permissiveness of germ cells to be reprogrammed into 
neurons. Furthermore, SPT-16 is part of both a somatic and a germline-specific complex and 
we could previously demonstrate that gut cells can be reprogrammed to neuron-like cells upon 
RNAi knock-down of spt-16 and broad CHE-1 expression using RNAi1,104. If spt-16 was to 
be down-regulated in the F55A3.7(ok1829) mutant background, we would have expected to 
see the same, but germline conversion was the only phenotype we experienced upon broad 
CHE-1 induction in F55A3.7(ok1829) animals. It is worth mentioning, that on the other hand, 
we could never show germline reprogramming in animals where we knocked-down spt-16 
with RNAi, because spt-16 F1 RNAi during embryonic development is causing early lethality. 
F1 RNAi is needed to assay for conversion of germ cells, as shown for the depletion of hmg-3 
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or other previously identified factors such as lin-5383,84 (section 1.4). Interestingly, using 
RNAi against F55A3.7 resulted in intestinal cells starting to convert to neurons upon broad 
CHE-1 induction1,104, unlike the deletion mutant F55A3.7(ok1829) where we could just see 
germ-cell reprogramming. This counter-intuitive result can be easily explained by the high 
sequence homology between the pseudogene F55A3.7 and its mother gene spt-16, so F55A3.7 
RNAi also targeted spt-16 transcripts, resulting in a spt-16 knock-down phenotype and 
displaying the same lethality in an F1 screen that has been explained above.   
Finally I could demonstrate that F55A3.7 acts in trans by doing rescue experiments (Figure 
34), thus confirming that active transcription of F55A3.7 is needed for it to fulfill its function 
and that the transdifferentiation phenotype we observe is not due to an enhancer element that 
got deleted in the F55A3.7(ok1829) deletion allele.    
 
3.5 Gonad specific transcriptome and epigenetic landscape analysis in F55A3.7 
depleted worms  
We performed germline-specific RNA-seq and ATAC-seq in order to identify a potential 
mechanism of how the non-coding RNA F55A3.7 safeguards germ cell identity (section 
2.2.5). While the RNA-seq data has a rather low read depth, based on our experience with 
NGS of C. elegans, the read depth of the ATAC-seq data looks much better and covers many 
more genes. Despite the fact that we might repeat the RNA-seq experiment with a higher 
input amount of dissected gonads, we already have several overlapping genes that are high-
confidence candidates for an enhancer/suppressor screen.   
Furthermore I compared the data for down-regulated genes of RNA-seq and more closed 
genes of ATAC-seq with a set of genes that we previously identified as potential 
reprogramming barriers of induced transdifferentiation into a neuronal lineage by a genome-
wide RNAi screen1, which is giving me another set of high-confidence candidates to test. In 
my ongoing experiments I am at the moment knocking down these candidates in the 
F55A3.7(ok1829) mutant background and check if upon ectopic induction of che-1 the 
reprogramming efficiency of a germ cell to neuron conversion would be enhanced or 
suppressed.    
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Taken together, F55A3.7 plays a role is safeguarding cell identity of the germline 
independently of its mother gene spt-16 or other FACT members. It therefore must act 
through another mechanism which still needs to be elucidated. My RNA-seq and ATAC-seq 
data provided us with lots of clues in this regard and I am currently using this information to 
conduct enhancer and suppressor RNAi screens. 
Generally, reprogramming barriers are often evolutionarily conserved: FACT safeguards 
germline and intestinal fate in C. elegans and also safeguards cell identity of human 
fibroblasts1. LIN-53 (CAF-1p48/RBBP7 in mammals) is another reprogramming barrier that 
safeguards germline fate in C. elegans. Additionally, the LIN-53-containing histone chaperone 
CAF-1 acts as a barrier of reprogramming murine fibroblasts83,85. Naturally, metazoan 
organisms need to prevent induction of ectopic gene expression programs in order to be 
successful and therefor such evolutionary conservation is quite likely.   
Due to this fact, C. elegans can serve as a very versatile and powerful model organism to 
identify such evolutionary conserved reprogramming barriers or other genes, as also 
demonstrated in this thesis.    
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4 Material & Methods 
4.1 Nematode culture 
C. elegans strains were maintained on nematode growth medium (NGM) seeded with OP50 
bacteria at 15 °C, 20 °C or 25 °C as described previously3. Temperature was chosen according 
to the experimental setup. If not mentioned otherwise, the temperature used was 20 °C.  
4.2 Transgenesis in C. elegans  
4.2.1 Microinjection into C. elegans’ gonads 
Using a fine needle, DNA can be directly injected into the germline of C. elegans, where it 
usually forms an extrachromosomal array that is transmitted to some individuals of the F1 
offspring123. Usually, besides the DNA of interest, a marker is used to distinguish animals that 
carry an extrachromosomal array from the ones that don’t. Typical markers are for instance 
the phenotypic marker rol-6 (the plasmid pRF4 encodes rol-6(su1006), which is a dominant 
mutation of a collagen gene that leads to a horseshoe-shaped movement)124, myo-2p::mCherry 
(expression only in the pharynx of the worm)125 or the antibiotic resistance gene against 
Hygromycin126. In order to generate extrachromosomal arrays where germline expression was 
needed, a complex array strategy was used127. Using this strategy, the DNA concatamerizes, 
which prevents the formation of highly repetitive arrays, that are usually silenced in the germ 
line128. 
Microinjections where done by Sergej Herzog or Alina El-Khalili. 
4.2.2 Integration of extrachromosomal arrays with γ-irradiation 
Extrachromosomal arrays can be integrated into the genome using γ-irradiation. To do so, 150 
L4 larvae or young adults are irradiated at 4.000 rad. Subsequently, worms are transferred to 
fresh plates with 5 worms each. After the worms propagated and went into starvation (usually 
10 - 12 days at 20 °C), plates are chunked and 10 worms of each plate are singled the next 
day. The next generation is scored for the transmission rate of the extrachromosomal array. 
Animals that give 100 % positive transgenic F1s are considered to be integrated. Resulting 
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lines need to be backcrossed to WT animals 3 - 5x to reduce the amount of unwanted 
mutations caused by the γ-irradiation.    
4.2.3 Universal MosSCI 
MosSCI is a method to insert a single copy of a transgene into a well-defined location in the 
C. elegans genome (see section 1.2.2.1). Universal MosSCI sites are insertion sites that allow 
insertion of the same transgene at several well-defined locations with the advantage that one 
targeting vector is compatible with multiple insertion sites based on the strain that is used for 
mircoinjection. Universal MosSCI was applied following the instructions of 
www.wormbuilder.org 
4.2.4 Gene tagging using CRISPR/Cas9 
FLAG-tagging of F55A3.7 to generate BAT1594, HA-tagging of hmg-3 to generate BAT1559 
and HA-tagging of hmg-4 to generate BAT1967 was performed using the CRISPR/Cas system 
following the instructions from Arribere et al.129. The injection mixes contained a PCR repair 
template to introduce the tag (90ng/μl, ~50bp homology arms), a plasmid that drives Cas9 
expression (Addgene #46168) and a plasmid expressing the sgRNA targeting the F55A3.7 
(dBT625, 50ng/μl), hmg-3 (dBT620, 50ng/μl) or hmg-4 (dBT621, 50ng/μl) locus. 
Furthermore a dpy-10 co-CRISPR approach was used129 to facilitate screening, so the 
injection mix also contained a dpy-10(cn64) PAGE-purified 99mer single-stranded 
oligodeoxynucleotide (ssODN) HR template (50ng/μL; IDT) and a plasmid that drives 
expression of dpy-10(cn64) sgRNA (dBT618, 50ng/μl). Successful knock-in was confirmed 
by Sanger sequencing (Eurofins). 
4.3 Transgenic crosses of C. elegans 
Mating was done by transferring 7 males of one strain and 3 hermaphrodites of another strain 
to a plate with only limited availability of food. This enforced the worms to stay in close 
proximity, thus increasing the chance of successful mating. Prior to that, WT (N2) males were 
crossed into a strain to generate males of this strain if otherwise no males were available. 
Genotypes were monitored by phenotypical markers and/or by genotyping.    
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4.4 Identification of the mutated bar18 locus with WGS 
To identify the mutated bar18 locus, I applied a Hawaiian SNP crossing strategy and 
combined it with whole-genome sequencing (WGS) as described by Doitsidou et al.105. Using 
this strategy I introduced Hawaiian SNPs through crossing and homologous recombination 
into the genome of the mutant and then narrowed down the location of the mutation following 
WGS. After each cross, only animals that still show the mutant phenotype are analyzed and, 
as a result, fewer or no Hawaiian SNPs will be found around the bar18 locus, making it 
possible to identify it. 
Briefly, I crossed bar18 mutant (BAT173) and WT (BAT60) animals with Hawaiian CB4856 
males and singled F1 cross progeny. After they self-fertilized and propagated, I singled 41 
independent F2s of bar18 worms that showed the nuclei displacement phenotype and 36 
independent F2s of WT worms to fresh plates and allowed them to self-fertilize. After their 
progeny populated 6 cm NGM plates, worms were washed off with M9 and their DNA was 
isolated using the Gentra Puregene Tissue Kit (Qiagen, #158689) according to the 
manufacturer’s instructions. Pooled DNA samples of bar18 and WT worms were used to 
prepare libraries with the Paired-End Sample Prep Kit (Illumina #PE-102-1002) according to 
the manufacturer’s protocol. Libraries were subjected to WGS on an Illumina HiSeq 2500 
System, using single 100 nucleotide reads. Bioinformatic analysis was done using the Galaxy-
based CloudMap tool according Minevich et al.106. 
4.5 Microscopic analysis of bar18 phenotype 
To quantify the nuclei dispositioning phenotype penetrance (Fig. 1B), living worms were 
assessed under a fluorescent dissecting microscope. To count total numbers of GFP-positive 
nuclei, worms were immobilized with polystyrene microspheres as described by Fang-Yen et 
al.130. I took image stacks of whole worms using a Leica DM6B-Z microscope. Stacks were 
opened using Fiji (http://fiji.sc) and nuclei quantified with the help of the multi-selection tool 
to mark counted nuclei. Sex muscles (vulva and uterine muscles) were excluded when 
counting. 
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4.6 Lifespan assays 
To monitor the lifespan of different strains, synchronized eggs were put on OP50 plates and 
worms were grown until L4 stage at 15 °C. Subsequently, L4 larvae were transferred to 
FUDR plates and shifted to 20 °C. FUDR inhibits DNA synthesis and prevents the hatching of 
eggs and larval growth131,132, so worms that are monitored for their lifespan are not overgrown 
by their progeny. The lifespan was scored every day by counting the number of dead vs. alive 
animals. Data was analyzed using the online application for survival analysis 2 (OASIS 2)107.   
4.7 Swimming assays 
Swimming assays are one way to analyze the motility of worm quantitatively. To do so, a single worm 
was transferred to a droplet of M9 buffer (10 µl) and filmed by a microscope camera. Videos were 
captured using a light microscope, DinoEye eye piece camera and VirtualDub 1.10.4 software, with 
the following parameters: 640x480 pixels, 16 seconds, 30 frames per second. The videos were 
imported into ImageJ software, cutting the first second of each video to circumvent flickering of the 
first few frames. Subsequently, the videos where analyzed using the ImageJ plugin wrMTrck111 with 
the following parameters for the wrMTrck batch: fileTypeNr=1; imageType=1; backSub=0; 
threshMode=1; fixedThresh=13; skeletonize=0; movieDuration=0; fps=30; pixPrMm=0; minSize=40; 
maxSize=700; maxVelocity=100; maxAreaChange=500; minTrackLength=20; bendThreshold=2; 
bendDetect=2; rawData=0; delFirst=0. Finally the body bends per second were calculated by dividing 
the measured amount of body bends by the time.  
4.8 Exploration assays 
An exploration assay measures exploration behavior based on movement across a bacterial 
lawn that has a grid applied to it. They were performed as previously reported110. Briefly, 
individual L4 animals were transferred to a 6 cm agar dish seeded with OP50. After ~16 h, the 
worm was removed and the plate imposed to grid with 3,5 mm squares and the number of 
squares entered was manually counted and squares entered per hour was calculated.   
81 
 
4.9 RNAi experiments 
RNAi plates were made from NGM-Agar, additionally supplemented with IPTG (1 mM final 
concentration) and carbenicillin (50 µg/µl final concentration) and seeded with 100 µl 
overnight culture of RNAi bacteria (HT115). HT115 bacteria contain an IPTG-dependent T7 
polymerase to express dsRNA70 (section 1.2.2.2). Additionally their dsRNA RNaseIII gene is knocked 
out and substituted with a tetracycline resistance. RNAi bacteria were streaked out on LB-agar plates 
containing ampicillin or carbenicillin (selection for the RNAi plasmid) and tetracycline (selection for 
RNaseIII disruption). From those plates, overnight cultures of HT115 were done in LB medium 
containing only ampicillin, since tetracycline would have influenced RNAi efficiency.  
For RNAi experiments, worms were grown on plates seeded with RNAi bacteria from 
Ahringer library (Source Bioscience). RNAi against Renilla luciferase (Rluc) was used as 
negative control. Experimental procedures followed a standard RNAi feeding protocol72.  
4.10 Immunostaining of C. elegans 
For anti-FLAG staining (Anti-FLAG mono mouse antibody, Sigma, at 1:1000 dilution), 
whole worms were fixed and permeabilized as described previously described method133. 
Briefly, worms were washed 3x and resuspended in RFB (160 mM KCl; 40 mM NaCl; 20 
mM EGTA; 10 mM Spermidine) + 2% formaldehyde, followed by three freeze-thaw cycles 
and an incubation for 30 minutes at 25 °C. After that, samples were washed with TTE (100 
mM Tris pH 7,4; 1 % Triton; 1mM EDTA) and incubated for 4 h at 37°C with shaking in TTE 
+ 1% beta-Mercaptoethanol. After that, samples were washed in BO3 buffer (10 mM H3BO3; 
10 mM NaOH; 2 % Triton) and incubated for 15 min at 37°C with shaking in BO3 buffer + 
10 mM DTT. Following another wash with BO3, samples were incubated in BO3 buffer + 0,3 
% H2O2 for 15 minutes at 25 °C. After a final wash in BO3, samples were blocked 0,2 % 
gelatin + 0,25 % Triton in PBS and stained. Fixed worms were incubated in Anti-FLAG 
diluted primary antibody (1:1000 in PBS with 0,25 % Triton + 0,2 % gelatin) overnight at 4 
°C. After washing in PBS + 0,25 % Triton, secondary antibodies (AlexaFluor488 Goat Anti-
MouseAlexa, Molecular Probes, at 1:1500 dilution) were applied and incubated overnight at 
4°C. Finally, samples were washed in PBS + 0,25 % Triton and mounted on glass slides with 
DAPI-containing mounting medium (Dianove, #CR-3448).  
Anti-HA staining was performed in the exactly same manner, only using another primary 
antibody (anti-HA mono mouse antibody, Roche, at 1:1000 dilution). 
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4.11 cDNA preparation and qRT-PCR 
For gonad specific qRT-PCR, 20 gonads per replicate were dissected and RNA was isolated 
using Rneasy Micro Kit (Qiagen) according to the manufacturer’s instructions. cDNA was 
generated using oligo-dT and random hexamer primers with the GoScript Reverse 
Transcriptase Kit (Promega) was used according to the manufacturer’s instructions. 
4.12 Western blots 
BAT1558 worms were checked for the presence of a possible F55A3.7 protein. BAT748 was 
used as a positive control for the anti-FLAG-HRP antibody. Those worms were heat-shocked 
(30 min @ 37°C) and subsequently 42 worms were picked. Washed off N2 worms served as a 
negative control for the anti-FLAG-HRP antibody. Worms of BAT1749 and BAT1753 were 
checked for the presence of HMG3::3xHA, SPT-16 and LIN-53 and α-tubulin was used as a 
loading control. Synchronized young adult worms were washed and pelleted (300 g, 1 
minute). Pellets were resuspended in 1x SDS sample buffer (60 mM Tris-HCl (pH 6,8), 10% 
glycerol, 2% SDS, 1% 14,3 M β-2-mercaptoethanol, 0,02% bromophenol blue, final 
concentrations). To lyse the samples, they were boiled at 95 °C for 10 minutes buffer. Next, 
the worm lysates were centrifuged for 10 minutes at 20000 g. Worm lysates were then 
separated a 10% SDS-PAGE and proteins were transferred onto nitrocellulose blotting 
membranes (GE Healthcare Life Sciences). Subsequently, the membranes were blocked in 
Tris-Buffered Saline with 0,1% (w/v) Tween-20 (TBST) containing 0.5% Gelatine Silber 
(Roth). For protein detection, the blots were probed with primary antibodies (see Table 4) in 
3% TBST containing 3% BSA at 4°C. If secondary antibodies were needed, blots were 
washed in TBST and incubated with secondary antibodies (see Table 4). After a final washing 
step with TBST, blots were developed using Lumi-Light Western Blotting Substrate (Roche) 
and analysed with the ImageQuant LAS4000 software (GE Healthcare Life Sciences). To 
check for α-tubulin, blots were stripped: 2x 10 minutes wash in stripping buffer (15 g 
Glycine, 1 g SDS, 10 ml Tween20, in 1 l ddH2O; pH 2,2), 2x washed in PBS for 10 minutes 
and 2x washed in TBST for 5 minutes. Next the blots were blocked and incubated with 
primary and secondary antibodies as described previously. 
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Table 4. Antibodies used for Western blots. 
Primary 
antibody  
Clonality  Host  Dilution  Company  Secondary antibody  
Anti-α-tubulin  Monoclonal  Mouse  1:10000  Sigma  Anti-Mouse-HRP  
1:10000  
Santa Cruz Biotechnology 
Inc.  
Anti-FLAG-HRP  Monoclonal  Mouse  1:1000  Sigma  -  
Anti-HA-HRP  Polyclonal  Chicken  1:1000  Abcam  -  
Anti-LIN-53  Monoclonal  Rabbit  1:2000  Pineda  Anti-rabbit-HRP  
1:10000  
Santa Cruz Biotechnology 
Inc.  
Anti-SPT-16  Monoclonal  Guinea pig  1:2000  Pineda  Anti-Guinea pig-HRP  
1:10000  
Santa Cruz Biotechnology 
Inc.  
4.13 Transdifferentiation assays (heat-shock induction of che-1) 
To induce che-1 expression in hsp-16.2::che-1 strains, L4 larvae were incubated at 37 °C for 
30 minutes and kept overnight at 25 °C. 
4.14 RNA-seq 
For gonad specific qRT-PCR, 20 gonads per replicate were dissected and RNA was isolated 
using Rneasy Micro Kit (Qiagen) according to the manufacturer’s instructions. Ribosomal 
RNA depletion (Ribo-Zero, Illumina) was performed according to the manufacturer’s 
instructions. The libraries were prepared using NEXTflex Rapid Directional qRNA-Seq Kit 
(Bioo Scientific) according to the manufacturer’s instructions. The libraries were sequenced 
using paired end sequencing length of 75 nucleotides on a HiSeq4000 machine (Illumina). 
4.15 ATAC-seq 
For gonad specific ATAC-seq, 20 gonads per replicate were dissected and nuclei were isolated 
using a plastic dounce homogenizer with 50 strokes tight-fitting insert in buffer A (15 mM 
Tris–HCl pH7,5, 2 mM MgCl2, 340 mM sucrose, 0,2 mM spermine, 0,5 mM spermidine, 0,5 
mM phenylmethanesulfonate [PMSF], 1mM DTT, 0,1% Trition X-100 and 0.25% NP-40 
substitute) as described before134,135. The debris was removed by spinning at 100g for 5 
minutes and nuclei were counted by Methylene blue staining. 100000 nuclei per sample were 
pelleted by spinning at 1000g for 10 minutes and proceeded immediately to transposition step 
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of the ATACseq protocol as described previously114. Libraries were amplified for a total of 10 
to 18 cycles and sequenced using paired-end-sequencing length of 75 nucleotides using 
NextSeq 500/550 High Output v2 kit (Illumina). 
4.16 List of worm strains used 
BAT28 otIs305 (hsp::che-1::3xHA) V; ntIs1 (gcy-5::GFP) V 
BAT60 ccIs4251 [myo-3p::DFP(NLS)::LacZ (pSAK2) + myo-3p::GFP(mitochondrially 
targeted) (pSAK4) + dpy-20 (+)] I. stIs10166 [dpy-7p::HIS-24::mCherry + unc-119(+)] 
III. barIs19 [hsp-16.2::hlh-1 + rol-6 (su1006]) X. 
BAT173  barIs19 (hsp-16.2p::hlh-1+rol-6), ccls4251 I [myo-3p::gfp::NLS], stIs10166 (dpy-
7p::mCherry), bar18 V.  
BAT197  ccls4251 I [myo-3p::gfp::NLS], unc-83(bar18) V.  
BAT372 F55A3.7(ok1829) I.; otIs305 [hsp::che-1::3xHA] ntIs1 [gcy-5::GFP] V. 
BAT653  him-8(e1489) IV.  
BAT661  ccls4251 I [myo-3p::gfp::NLS].  
BAT748  barEx308 [hsp-16.2::H3_S10E::2xFLAG, hsp-16.2::His-71_S10E::2xFLAG, myo-
2p::mCherry], otIs305 [hsp-16.2p::che-1::3xHA, rol-6(su1006)] ntIs1 [gcy-5p::GFP, 
lin-15(+)] V.  
BAT968 ccls4251 [myo-3p::gfp] I; unc-84(e1174) X. 
BAT1099  rrrSi261 [myo-3pr::cey-4genomic::operon(gfp::h2b::tbb 3'UTR); unc-119(+)] I. unc-83 
(bar18) V.  
BAT1298  barEx453 [myo-3p::unc-83_cDNA::SL2::NLS::tagRFP::tbb-2_3'UTR, myo-
2p::mCherry, HygR].  
BAT1300 barIs219 [eft-3p::unc-83_cDNA::SL2::NLS::tagRFP::tbb-2_3'UTR, myo-2p::mCherry, 
HygR] 
BAT1468 barIs165 [myo-3p::lmn-1T40I::2xFLAG::SL2::NLS::tagRFP] 
BAT1488  rrrSi261 [myo-3pr::cey-4genomic::operon(gfp::h2b::tbb 3'UTR); unc-119(+)] I.  
BAT1559 hmg-3(bar24[hmg-3::3xHA]) I 
BAT1594  F55A3.7-16(bar23[F55A3.7::3xFLAG]) I.  
BAT1749  hmg-3(bar24[hmg-3::3xHA]) I; F55A3.7(ok1829) I.  
BAT1753  hmg-3(bar24[hmg-3::3xHA]) I.  
BAT1906 barEx1031 [myo-3p::3xFLAG::unc-83::unc-54_3'_UTR + ttx-3::mCherry + HygR]; 
ccls4251 [myo-3p::gfp]; unc-83(bar18) V. 
BAT1907 barEx1032 [myo-3p::3xFLAG::unc-83::unc-54_3'_UTR + ttx-3::mCherry + HygR]; 
ccls4251 [myo-3p::gfp]; unc-83(bar18) V. 
BAT1909 barEx1034 [myo-3p::3xFLAG::unc-83::unc-54_3'_UTR + ttx-3::mCherry + HygR]; 
ccls4251 [myo-3p::gfp]; unc-83(bar18) V. 
BAT1956 F55A3.7(ok1829) I.; otIs305 [hsp::che-1::3xHA] ntIs1 [gcy-5::GFP] V; barEx1023 
(sspt-16p::sspt-16::sspt-16_UTR, ttx-3::mCherry, HygR) 
BAT1957 F55A3.7(ok1829) I.; otIs305 [hsp::che-1::3xHA] ntIs1 [gcy-5::GFP] V; barEx1024 
(sspt-16p::sspt-16::sspt-16_UTR, ttx-3::mCherry, HygR) 
BAT1959 F55A3.7(ok1829) I.; otIs305 [hsp::che-1::3xHA] ntIs1 [gcy-5::GFP] V; barEx1026 
(sspt-16p::sspt-16::sspt-16_UTR, ttx-3::mCherry, HygR) 
BAT1967 hmg-4(bar32[hmg-4::3xHA]) III 
N2 C. elegans wild isolate. (Bristol) 
CB4856 C. elegans wild isolate. (Hawaii) 
RB1524  F55A3.7(ok1829) I.  
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4.17 List of plasmids used 
Addgene #46168 Peft-3::cas9-SV40_NLS::tbb-2 3'UTR 
pRF4 rol-6(su1006) 
pCFJ90 Pmyo-2:mCherry:unc-54 UTR 
dBT618 dpy-10 sgRNA 
dBT620 hmg-3 sgRNA 
dBT621 hmg-4sgRNA 
dBT625 F55A3.7 sgRNA 
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